CN105612171B - The method for adjusting the seed in plant and organ size - Google Patents
The method for adjusting the seed in plant and organ size Download PDFInfo
- Publication number
- CN105612171B CN105612171B CN201480045197.9A CN201480045197A CN105612171B CN 105612171 B CN105612171 B CN 105612171B CN 201480045197 A CN201480045197 A CN 201480045197A CN 105612171 B CN105612171 B CN 105612171B
- Authority
- CN
- China
- Prior art keywords
- plant
- polypeptide
- expression
- seq
- eod1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 94
- 210000000056 organ Anatomy 0.000 title claims abstract description 47
- 101100442074 Arabidopsis thaliana DA2 gene Proteins 0.000 claims abstract description 323
- 101000851892 Homo sapiens Tropomyosin beta chain Proteins 0.000 claims abstract description 281
- 230000014509 gene expression Effects 0.000 claims abstract description 195
- 230000000694 effects Effects 0.000 claims abstract description 115
- 230000002829 reductive effect Effects 0.000 claims abstract description 41
- 230000001965 increasing effect Effects 0.000 claims abstract description 25
- 241000196324 Embryophyta Species 0.000 claims description 348
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 189
- 229920001184 polypeptide Polymers 0.000 claims description 185
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 185
- 150000007523 nucleic acids Chemical class 0.000 claims description 154
- 210000004027 cell Anatomy 0.000 claims description 148
- 102000039446 nucleic acids Human genes 0.000 claims description 137
- 108020004707 nucleic acids Proteins 0.000 claims description 137
- 230000035772 mutation Effects 0.000 claims description 77
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 41
- 239000002773 nucleotide Substances 0.000 claims description 36
- 125000003729 nucleotide group Chemical group 0.000 claims description 36
- 240000007594 Oryza sativa Species 0.000 claims description 25
- 235000007164 Oryza sativa Nutrition 0.000 claims description 25
- 235000009566 rice Nutrition 0.000 claims description 25
- 210000004899 c-terminal region Anatomy 0.000 claims description 20
- 238000010276 construction Methods 0.000 claims description 17
- 230000009467 reduction Effects 0.000 claims description 15
- 239000002253 acid Substances 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 101100493739 Arabidopsis thaliana BB gene Proteins 0.000 claims description 11
- 240000008042 Zea mays Species 0.000 claims description 11
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 11
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 11
- 235000005822 corn Nutrition 0.000 claims description 11
- 230000012010 growth Effects 0.000 claims description 10
- 230000003834 intracellular effect Effects 0.000 claims description 9
- 230000001568 sexual effect Effects 0.000 claims description 8
- 240000005979 Hordeum vulgare Species 0.000 claims description 6
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 6
- 235000021307 Triticum Nutrition 0.000 claims description 6
- 235000010469 Glycine max Nutrition 0.000 claims description 5
- 244000068988 Glycine max Species 0.000 claims description 5
- 235000011331 Brassica Nutrition 0.000 claims description 4
- 241000219198 Brassica Species 0.000 claims description 4
- 235000002566 Capsicum Nutrition 0.000 claims description 4
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 3
- 240000003768 Solanum lycopersicum Species 0.000 claims description 3
- 230000002401 inhibitory effect Effects 0.000 claims description 3
- 230000001629 suppression Effects 0.000 claims description 3
- 235000016068 Berberis vulgaris Nutrition 0.000 claims description 2
- 241000335053 Beta vulgaris Species 0.000 claims description 2
- 244000157790 Buglossoides arvense Species 0.000 claims description 2
- 235000004256 Buglossoides arvense Nutrition 0.000 claims description 2
- 244000025254 Cannabis sativa Species 0.000 claims description 2
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 claims description 2
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 claims description 2
- 240000008574 Capsicum frutescens Species 0.000 claims description 2
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 2
- 244000241257 Cucumis melo Species 0.000 claims description 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims description 2
- 244000000626 Daucus carota Species 0.000 claims description 2
- 235000002767 Daucus carota Nutrition 0.000 claims description 2
- 235000009355 Dianthus caryophyllus Nutrition 0.000 claims description 2
- 240000006497 Dianthus caryophyllus Species 0.000 claims description 2
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 2
- 240000009088 Fragaria x ananassa Species 0.000 claims description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 2
- 244000020551 Helianthus annuus Species 0.000 claims description 2
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 2
- 235000003228 Lactuca sativa Nutrition 0.000 claims description 2
- 240000008415 Lactuca sativa Species 0.000 claims description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 claims description 2
- 240000006240 Linum usitatissimum Species 0.000 claims description 2
- 239000006002 Pepper Substances 0.000 claims description 2
- 235000016761 Piper aduncum Nutrition 0.000 claims description 2
- 240000003889 Piper guineense Species 0.000 claims description 2
- 235000017804 Piper guineense Nutrition 0.000 claims description 2
- 235000008184 Piper nigrum Nutrition 0.000 claims description 2
- 235000010582 Pisum sativum Nutrition 0.000 claims description 2
- 240000004713 Pisum sativum Species 0.000 claims description 2
- 235000007238 Secale cereale Nutrition 0.000 claims description 2
- 244000082988 Secale cereale Species 0.000 claims description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 2
- 244000061456 Solanum tuberosum Species 0.000 claims description 2
- 241001116500 Taxus Species 0.000 claims description 2
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims description 2
- 230000000735 allogeneic effect Effects 0.000 claims description 2
- 235000009120 camo Nutrition 0.000 claims description 2
- 239000001390 capsicum minimum Substances 0.000 claims description 2
- 235000005607 chanvre indien Nutrition 0.000 claims description 2
- 235000004426 flaxseed Nutrition 0.000 claims description 2
- 239000011487 hemp Substances 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims description 2
- 239000002777 nucleoside Substances 0.000 claims description 2
- 125000003835 nucleoside group Chemical group 0.000 claims description 2
- 235000013311 vegetables Nutrition 0.000 claims description 2
- 244000061176 Nicotiana tabacum Species 0.000 claims 1
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 108010083111 Ubiquitin-Protein Ligases Proteins 0.000 abstract description 20
- 102000006275 Ubiquitin-Protein Ligases Human genes 0.000 abstract description 19
- 230000002195 synergetic effect Effects 0.000 abstract description 14
- 108090000623 proteins and genes Proteins 0.000 description 55
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 34
- 101150102138 GW2 gene Proteins 0.000 description 33
- 239000004055 small Interfering RNA Substances 0.000 description 28
- 108090000848 Ubiquitin Proteins 0.000 description 26
- 102000044159 Ubiquitin Human genes 0.000 description 26
- 238000005516 engineering process Methods 0.000 description 26
- 108091028043 Nucleic acid sequence Proteins 0.000 description 22
- 230000002708 enhancing effect Effects 0.000 description 22
- 235000018102 proteins Nutrition 0.000 description 22
- 102000004169 proteins and genes Human genes 0.000 description 22
- 235000001014 amino acid Nutrition 0.000 description 21
- 230000035040 seed growth Effects 0.000 description 20
- 229940024606 amino acid Drugs 0.000 description 19
- 239000000047 product Substances 0.000 description 19
- 108020004459 Small interfering RNA Proteins 0.000 description 18
- 150000001413 amino acids Chemical class 0.000 description 18
- 230000034512 ubiquitination Effects 0.000 description 18
- 238000010798 ubiquitination Methods 0.000 description 18
- 241000219194 Arabidopsis Species 0.000 description 17
- 230000008859 change Effects 0.000 description 16
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 14
- 108020004999 messenger RNA Proteins 0.000 description 14
- 108091070501 miRNA Proteins 0.000 description 14
- 230000021368 organ growth Effects 0.000 description 14
- 238000012300 Sequence Analysis Methods 0.000 description 13
- 108091027967 Small hairpin RNA Proteins 0.000 description 13
- 230000003993 interaction Effects 0.000 description 13
- 210000001519 tissue Anatomy 0.000 description 13
- 108700028369 Alleles Proteins 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 12
- 238000011161 development Methods 0.000 description 12
- 230000018109 developmental process Effects 0.000 description 12
- 238000003780 insertion Methods 0.000 description 12
- 230000037431 insertion Effects 0.000 description 12
- 239000002679 microRNA Substances 0.000 description 12
- 230000001105 regulatory effect Effects 0.000 description 12
- 230000000875 corresponding effect Effects 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 230000009261 transgenic effect Effects 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 230000002596 correlated effect Effects 0.000 description 10
- 108020001507 fusion proteins Proteins 0.000 description 10
- 102000037865 fusion proteins Human genes 0.000 description 10
- 238000005259 measurement Methods 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 9
- 230000004663 cell proliferation Effects 0.000 description 9
- 238000000338 in vitro Methods 0.000 description 9
- 239000013612 plasmid Substances 0.000 description 9
- 238000013518 transcription Methods 0.000 description 9
- 230000035897 transcription Effects 0.000 description 9
- 101150073709 DA2 gene Proteins 0.000 description 8
- 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 8
- 230000000692 anti-sense effect Effects 0.000 description 8
- 235000013339 cereals Nutrition 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 230000001276 controlling effect Effects 0.000 description 8
- 230000002018 overexpression Effects 0.000 description 8
- 108020003175 receptors Proteins 0.000 description 8
- 102000005962 receptors Human genes 0.000 description 8
- 239000011701 zinc Substances 0.000 description 8
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 7
- 101150014221 Son gene Proteins 0.000 description 7
- 230000015556 catabolic process Effects 0.000 description 7
- 238000006731 degradation reaction Methods 0.000 description 7
- 230000009368 gene silencing by RNA Effects 0.000 description 7
- 238000007689 inspection Methods 0.000 description 7
- 230000008774 maternal effect Effects 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- 238000006467 substitution reaction Methods 0.000 description 7
- 230000009182 swimming Effects 0.000 description 7
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 6
- 108700030285 Arabidopsis DA2 Proteins 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000009396 hybridization Methods 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241000589158 Agrobacterium Species 0.000 description 5
- 239000002028 Biomass Substances 0.000 description 5
- 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 5
- 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 5
- 238000011529 RT qPCR Methods 0.000 description 5
- 241000209140 Triticum Species 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 5
- 238000009395 breeding Methods 0.000 description 5
- 230000001488 breeding effect Effects 0.000 description 5
- 230000000295 complement effect Effects 0.000 description 5
- 230000008030 elimination Effects 0.000 description 5
- 238000003379 elimination reaction Methods 0.000 description 5
- 239000003623 enhancer Substances 0.000 description 5
- 230000002255 enzymatic effect Effects 0.000 description 5
- 210000001339 epidermal cell Anatomy 0.000 description 5
- 230000004720 fertilization Effects 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 238000003119 immunoblot Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 108700031135 Arabidopsis DA1 Proteins 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 108010068086 Polyubiquitin Proteins 0.000 description 4
- 102100037935 Polyubiquitin-C Human genes 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000013599 cloning vector Substances 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000012252 genetic analysis Methods 0.000 description 4
- 238000001114 immunoprecipitation Methods 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 230000009456 molecular mechanism Effects 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000006798 recombination Effects 0.000 description 4
- 238000005215 recombination Methods 0.000 description 4
- 238000003757 reverse transcription PCR Methods 0.000 description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- 102100023826 ADP-ribosylation factor 4 Human genes 0.000 description 3
- 229920000856 Amylose Polymers 0.000 description 3
- 101100058846 Arabidopsis thaliana CYP78A5 gene Proteins 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- -1 DA1 nucleic acid Chemical class 0.000 description 3
- 102220563226 DALR anticodon-binding domain-containing protein 3_N91L_mutation Human genes 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 101000684189 Homo sapiens ADP-ribosylation factor 4 Proteins 0.000 description 3
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 3
- 108091028664 Ribonucleotide Proteins 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 235000018417 cysteine Nutrition 0.000 description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
- 230000003828 downregulation Effects 0.000 description 3
- 238000004043 dyeing Methods 0.000 description 3
- 102000057593 human F8 Human genes 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 210000001161 mammalian embryo Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 210000004940 nucleus Anatomy 0.000 description 3
- 230000010152 pollination Effects 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 229940047431 recombinate Drugs 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000002336 ribonucleotide Substances 0.000 description 3
- 125000002652 ribonucleotide group Chemical group 0.000 description 3
- 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 101100058847 Arabidopsis thaliana CYP78A6 gene Proteins 0.000 description 2
- 101100442073 Arabidopsis thaliana DA2L gene Proteins 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 101150008235 DA1 gene Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 101150066002 GFP gene Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 108010021466 Mutant Proteins Proteins 0.000 description 2
- 102000008300 Mutant Proteins Human genes 0.000 description 2
- 241000208125 Nicotiana Species 0.000 description 2
- 108091092724 Noncoding DNA Proteins 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 2
- 108030001238 RING-type E3 ubiquitin transferases Proteins 0.000 description 2
- 102000034442 RING-type E3 ubiquitin transferases Human genes 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 244000144987 brood Species 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 238000000749 co-immunoprecipitation Methods 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 229960000633 dextran sulfate Drugs 0.000 description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000003205 genotyping method Methods 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical class O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000011987 methylation Effects 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000003147 molecular marker Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 108020001580 protein domains Proteins 0.000 description 2
- 230000004850 protein–protein interaction Effects 0.000 description 2
- 239000011535 reaction buffer Substances 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000013605 shuttle vector Substances 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid Chemical compound CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 1
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical compound O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 description 1
- TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
- JXCKZXHCJOVIAV-UHFFFAOYSA-N 6-[(5-bromo-4-chloro-1h-indol-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid;cyclohexanamine Chemical compound [NH3+]C1CCCCC1.O1C(C([O-])=O)C(O)C(O)C(O)C1OC1=CNC2=CC=C(Br)C(Cl)=C12 JXCKZXHCJOVIAV-UHFFFAOYSA-N 0.000 description 1
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 1
- 101710197650 Actin-7 Proteins 0.000 description 1
- 108090000104 Actin-related protein 3 Proteins 0.000 description 1
- 241000186046 Actinomyces Species 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 101710134784 Agnoprotein Proteins 0.000 description 1
- 108700026409 Arabidopsis DAL2 Proteins 0.000 description 1
- 101100442072 Arabidopsis thaliana DA1 gene Proteins 0.000 description 1
- 101100330721 Arabidopsis thaliana DAR1 gene Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 108091032955 Bacterial small RNA Proteins 0.000 description 1
- 244000119012 Bequaertiodendron magalismontanum Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 108091033409 CRISPR Proteins 0.000 description 1
- 238000010354 CRISPR gene editing Methods 0.000 description 1
- 239000005496 Chlorsulfuron Substances 0.000 description 1
- 241000218631 Coniferophyta Species 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000005561 Glufosinate Substances 0.000 description 1
- 239000005562 Glyphosate Substances 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 101001072191 Homo sapiens Protein disulfide-isomerase A2 Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- 241001071917 Lithospermum Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108700011259 MicroRNAs Proteins 0.000 description 1
- 101150097297 Nedd4 gene Proteins 0.000 description 1
- 241000207746 Nicotiana benthamiana Species 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 101150051391 PEX10 gene Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000921313 Phyllopodium Species 0.000 description 1
- 101710124584 Probable DNA-binding protein Proteins 0.000 description 1
- 102100036351 Protein disulfide-isomerase A2 Human genes 0.000 description 1
- 238000010240 RT-PCR analysis Methods 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920002334 Spandex Polymers 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 241000218636 Thuja Species 0.000 description 1
- 101710120037 Toxin CcdB Proteins 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 101800001117 Ubiquitin-related Proteins 0.000 description 1
- 108020004417 Untranslated RNA Proteins 0.000 description 1
- 102000039634 Untranslated RNA Human genes 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229960003896 aminopterin Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 239000002551 biofuel Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 230000009133 cooperative interaction Effects 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 239000012297 crystallization seed Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000012202 endocytosis Effects 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 230000001973 epigenetic effect Effects 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 230000037440 gene silencing effect Effects 0.000 description 1
- 230000008303 genetic mechanism Effects 0.000 description 1
- 230000004034 genetic regulation Effects 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 1
- 229940097068 glyphosate Drugs 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012133 immunoprecipitate Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 230000005257 nucleotidylation Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 208000030825 patent ductus arteriosus 2 Diseases 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000010399 physical interaction Effects 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 230000037039 plant physiology Effects 0.000 description 1
- 238000004161 plant tissue culture Methods 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 230000014639 sexual reproduction Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 108091069025 single-strand RNA Proteins 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 239000004759 spandex Substances 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 229960000268 spectinomycin Drugs 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 108091006106 transcriptional activators Proteins 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- 230000006663 ubiquitin-proteasome pathway Effects 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000005418 vegetable material Substances 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
- 238000001086 yeast two-hybrid system Methods 0.000 description 1
Landscapes
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
The present invention relates to plant E3 ubiquitin ligases (referred to as DA2), and seed and organ size are controlled with DA1 synergistic effect.The method for increasing plant products is provided, this method includes that the expression or activity of DA2 are reduced in lacking DA1 expression or active plant.The method for additionally providing the plant with increased yield and generating this kind of plant.
Description
Technical field
The present invention relates to the sizes of the seed and organ that change plant, such as the method to improve plant products.
Background technique
The size of seed and organ is on the agronomy under heredity control and ecological important character (Alonso-
Blanco,C.PNAS USA 96,4710-7(1999);Song,X.J.Nat Genet 39,623-30(2007);Weiss,
J.Int J Dev Biol 49,513-25(2005);Dinneny,J.R.Development 131,1101-10(2004);
Disch,S.Curr Biol 16,272-9(2006);Science 289,85-8(2000);Horiguchi,G.Plant J
43,68-78(2005);Hu,Y Plant J 47,1-9(2006);Hu,Y.Plant Cell 15,1951-61(2003);
Krizek,B.A.Dev Genet 25,224-36(1999);Mizukami,Y.PNAS USA 97,942-7(2000);Nath,
U.Science 299,1404-7(2003);Ohno,C.K.Development 131,1111-22(2004);Szecsi,
J.Embo J 25,3912-20(2006);White,D.W.PNAS USA 103,13238-43(2006);Horvath,
B.M.Embo J 25,4909-20(2006);Garcia,D.Plant Cell 17,52-60(2005).Seed and organ are most
Whole size is constant in given species, and seed and organ size variation are very big between species, this show plant have with
Coordinate and timely mode controls the regulatory mechanism of seed and organ growth.However, although the importance of seed and organ size,
About the final organ and the molecule of seed size that control in plant and knowing little for genetic mechanism.
Usage quantity trait locuses (QTL), which have been located in plant, is included in tomato, soybean, corn and rice
In the genetic regulation of seed size is studied.So far, in disclosed document, two kinds of genes authenticated
(Song,X.J.Nat Genet 39,623-30(2007);Fan,C.Theor.Appl.Genet.112,1164-1171
(2006)), both genes are potential two kinds of main QTL of rice granularity;But the molecular mechanism of these genes still needs
It illustrates.In arabidopsis, to the seed weight influenced in germplasm (accession) hybridization between Ler and Cvi and/or
A kind of locus of the ten of length is positioned { Alonso-Blanco, 1999 are same as above }, but not yet identifies corresponding gene.Most
Nearly research has revealed that AP2 and ARF2 participates in control seed size.Unfortunately, ap2 and arf2 mutant has than open country
The raw lower fertilizability of type (Schruff, M.C.Development 137,251-261 (2006);Ohto,M.A.PNAS USA
102,3123-3128(2005);Jofuku,K.D.PNAS USA 102,3117-3122(2005)).In addition, being planted using mutation
The research of object authenticated worked by cell proliferation or expand influence several positive and negatives regulation of organ size because
Son { Krizek, B.A.Dev Genet 25,224-36 (1999);Mizukami,Y.Proc Natl Acad Sci U S A
97,942-7(2000);Nath,U.Science 299,1404-7(2003);Ohno,C.K.Development 131,1111-
22(2004);Szecsi,J.Embo J 25,3912-20(2006);White,D.W.PNAS USA 103,13238-43
(2006);Horvath,B.M.Embo J25,4909-20(2006);Garcia,D.Plant Cell 17,52-60(2005).
Horiguchi,G.Plant J 43,68-78(2005);Hu,Y Plant J 47,1-9(2006)Dinneny,
J.R.Development 131,1101-10(2004))。
It is related to several factor known effect seed sizes of ubiquitin related activity.Growth limiting factor DA1 is ubiquitin receptor
And including combining two ubiquitin of ubiquitin to interact motif (UIM) in vitro, and da1-1 mutant is by influencing ovule
Parent integument and form big seed (Li et al. people, 2008).(it encodes E3 ubiquitinbond to an enhancer (EOD1) of da1-1
Enzyme BIG BROTHER (BB) (Disch et al., 2006;Li et al. people, 2008) seed size of the mutation collaboration enhancing da1-1 in
Phenotype, to indicate DA1 and EOD1/BB synergistic effect to control seed size.In rice, the wide volume that 2 (GW2) are weighed with grain of grain
The quantitative trait locus (QTL) of code E3 ubiquitin ligase is by limitation cell division come Control granularity (Song et al., 2007).
GW2 homologue (the Ta-GW2 in wheat is authenticated;Bednarek et al. is 2012).It needs to be encoded by rice qSW5/GW5
Agnoprotein matter come limit the granularity in rice (Shomura et al., 2008;Weng et al., 2008).GW5 is in yeast two-hybrid
Physically interact in measurement with poly- ubiquitin, thus show GW5 may participate in Ubiquitin-Proteasome Pathway (Weng et al.,
2008).However, whether both unclear factors work in maternal tissue in rice and/or zygote tissue.
Other factors for identifying the final size of both control seed and organ will not only promote to the size control in plant
The understanding of the mechanism of system, and can for example have in terms of improving crop yield and plant biomass for generating bio-fuel
There is a large amount of practical application.
Summary of the invention
The present inventor authenticated plant E3 ubiquitin ligase (referred to as DA2), pass through the pearl of limitation development seed
Cell Proliferation by regulates and controls the final size of seed and organ.It has been surprisingly found that DA2 and DA1 synergistic effect and independence
Seed and organ size are controlled in EOD1.As target therefore it can be used for improving plant products using DA2 and DA1 and/or EOD1.
An aspect of of the present present invention provides a kind of method of yield for increasing plant, comprising:
The expression or activity of the intracellular DA2 polypeptide of the plant are reduced,
Wherein the plant lacks DA1 expression or activity.
Another aspect provides a kind of methods of yield for increasing plant, comprising:
The expression or activity of the intracellular DA2 polypeptide of the plant are reduced,
Wherein the plant lacks EOD1 expression or activity.
Another aspect provides a kind of methods of yield for increasing plant, comprising:
The expression or activity of the intracellular DA2 polypeptide of the plant are reduced,
Wherein the plant lacks DA1 and EOD1 expression or activity.
Another aspect provides a kind of methods of yield for increasing plant, comprising:
The expression or activity of the intracellular DA2 polypeptide of the plant are reduced or eliminated, and;
I) expression or activity of the intracellular DA1 polypeptide are reduced or eliminated,
Ii the expression or activity of the intracellular EOD1) are reduced or eliminated, and/or
Iii) in the dominant negative DA polypeptide of the cell inner expression.
Another aspect provides a kind of methods for generating and having the plant of increased yield, comprising:
The expression for lacking both DA1, EOD1 or DA1 and EOD1 or active plant cell are provided,
It will be eliminated by conversion or the expression of DA2 polypeptide or active heterologous nucleic acids is inhibited to be incorporated in the plant cell,
And;
Plant described in cytothesis from one or more conversion.
Detailed description of the invention
Fig. 1 shows seed and organ size in da2-1 mutant.1A shows Col-0, da2-1 and 35S::DA2#1 kind
The projected area of son.Seed is divided into three groups (>0.13,0.12-0.13 and<0.12mm2).Every group of value is expressed as being analyzed
Total number seeds percentage.1B shows every silique number seeds of Col-0, da2-1 and 35S::DA2#1.Angle on stem
Fruit (from fourth angle fruit to the tenth silique) is for measuring every silique number seeds.1C shows Col-0, da2-1 and 35S::DA2#1
Every plant seed weight.1D shows every plant seed number of Col-0, da2-1 and 35S::DA2#1.1E show Col-0,
The height of da2-1 and 35S::DA2#1 plant.Numerical value (B-E) is provided as the average value ± SE relative to wild type numerical value, if
It is set to 100%.Compared to wild type, * *, P < 0.01 and *, P < 0.05 (student t inspection).Ruler item: F, 1cm;G, 1mm
Fig. 2 shows 4 day age plant (F) of Col-0 (left side), da2-1 (centre) and 35S::DA2#1 (right side) and Col-0
(on), da2-1 (centre) and 35S::DA2#1 (under) flower (G).
Fig. 3 shows DA1 and DA2 synergistic effect to control seed size.3A shows Col-0, da1-1, da2-1 and da1-1
The dry seeds of da2-1.3B shows 10 day age seedling of Col-0, da2-1, da1-1 and da1-1 da2-1 (from left to right).3C shows
The seed weight of Col-0, da1-1, da2-1 and da1-1 da2-1 out.3D shows Col-0, da1-ko1, da2-1 and da1-ko1
The seed weight of da2-1.Numerical value is provided as the average value ± SE relative to corresponding wild type numerical value, is arranged to 100%.It compares
In wild type, * *, P < 0.01 and *, P < 0.05 (student t inspection).Ruler item: A, 0.1mm;B, 1m
Fig. 4 shows DA1 and DA2 synergistic effect to control seed size.Upper left illustrate 10 day age Col-0, da1-1,
The cotyledon area of da2-1 and da1-1 da2-1 seedling.Upper right illustrates 10 day age Col-0, da1-ko1, da2-1 and da1-ko1
The cotyledon area of da2-1 seedling.Lower-left illustrates the fence in the cotyledon of Col-0, da1-1, da2-1 and da1-1da2-1 plumule
The average area of cell.Bottom right illustrates Col-0, da1-1, da1-1 da2-1, da1-ko1 da2-1, da1-ko1 dar1-1
With the projected area of da1-ko1 dar1-1 da2-1 seed.Numerical value is as the average value ± SE relative to corresponding wild type numerical value
It provides, is arranged to 100%.Compared to wild type, * *, P < 0.01 and *, P < 0.05 (student t inspection).Ruler item: A, 0.1mm;B,
1m
Fig. 5 shows the cell Proliferation in parent integument of the DA1 and DA2 synergistic effect to control development seed.(5A-5D) point
The mature ovule of Col-0, da1-1, da2-1 and da1-1 da2-1 are not shown.The ovule of da2-1 mutation collaboration enhancing da1-1 is big
It is small.
Fig. 6 shows (left figure) Col-0 × Col-0 (c/c) F1, da2-1 × da2-1 (d2/d2) F1, Col-0 × da2-1
(c/d2) projected area of F1 and da2-1 × Col-0 (d2/c) F1 seed and (middle graph) Col-0 × Col-0 (c/c) F1,
da1-ko1 da2-1×da1-ko1 da2-1(dd/dd)F1、Col-0×da1-ko1 da2-1(c/dd)F1、da1-ko1
The projected area of da2-1 × Col-0 (dd/c) F1 seed.Right figure is shown with da1-ko1 da2-1 double-mutant pollen pair
Da1-ko1/+da2-1/+ plant pollination, so as to cause the intracutaneous da1-ko1/+da2-1/+ (a) of da1-ko1/+da2-1/+ kind,
The hair of da1-ko1/+da2-1da2-1 (b), da1-ko1/da1-ko1 da2-1/+ (c) and da1-ko1 da2-1 (d) plumule
Projection seed area after educating.It measures come the da1-ko1/+da2- for da1-ko1 da2-1 double-mutant pollen fertilization of using by oneself
The projected area of the single seed of 1/+ plant.These seeds are mutated further Genotyping for da1-ko1 and da2-1.Number
It is uncorrelated to the variation of the size of these seeds (P > 0.05, student t are examined) according to display da1-ko1 and da2-1 mutation.Numerical value is made
To provide relative to the average value ± SE of corresponding wild type numerical value, it is arranged to 100%.Compared to wild type, * *, P < 0.01 (is learned
Raw t is examined).Ruler item: A-D, 0.5mm.
Fig. 7 shows the projected area of (left figure) Col-0, da1-1, da2-1 and da1-1 da2-1 maturation ovule;It is (intermediate
Figure) cell in 6DAP and 8DAP in the external integument of Col-0, da1-1, da2-1 and da1-1 da2-1 seed number;With
And (right figure) from the external integument length and cell number of single seed calculate in 6DAP and 8DAP Col-0, da1-1, da2-1 and
The average length of cell in the external integument of da1-1 da2-1 seed.
Fig. 8 A shows DA2 gene structure.Indicate initiation codon (ATG) and terminator codon (TAA).It is closed frame instruction
Coded sequence, open frame indicates 5 ' and 3 ' non-translational regions, and the line between frame indicates introne.T- in DA2 gene is shown
DNA insertion point (da2-1).Fig. 8 B shows the RING structural domain that DA2 protein includes prediction.
Fig. 9 shows the E3 ubiquitin ligase activity of DA2.By MBP-DA2 and the DA2 of mutation (MBP-DA2C59S and MBP-
DA2N91L) fusion protein is surveyed for E3 ubiquitin ligase activity in the presence of E1, E2 and His- ubiquitin (His-Ub)
It is fixed.Respectively by detecting ubiquitination egg with anti-His antibody (anti-His) and anti-MBP antibody (anti-MBP) immunoblotting (IB)
White matter.Lower arrow indicates MBP-DA2 protein, and upper arrow shows ubiquitination MBP-DA2 protein.
Figure 10 shows the projected area (above) of Col-0, da2-1, COM#6, COM#8 and COM#10 seed, wherein COM
It is the da2-1 Coding Sequence Transformed with DA2 driven by the promoter of their own;Col-0, da2-1, COM#6, COM#8 and
DA2 in the petal area (middle graph) of COM#10 plant and Col-0, da2-1, COM#6, COM#8 and COM#10 seedling
The quantitative Real time RT-PCR analysis (following figure) of gene expression.Numerical value (D and E) is as the average value ± SE relative to da2-1 numerical value
It provides, is arranged to 100%.Compared to da2-1 mutant, * *, P < 0.01 (student t inspection).
Figure 11 shows the expression pattern of DA2.11A shows the quantitative Real time RT-PCR analysis of DA2 gene expression.From root (R),
Stem (S), leaf (L), seedling (Se) and inflorescence (In) separate total serum IgE.11B-11N is shown to be supervised by pDA2:GUS transgene expression
The DA2 expression activity of survey.It observes four GUS expression systems, and all shows similar mode, although they are in the strong of dyeing
Degree aspect is slightly different.4 day age seedling (11B), 10 day age seedling (11C), the inflorescence (11D) spent, the petal (11E- just developed
11G), in the stamen (11H and 11I) just developed, the carpel (11J-11L) just developed and the ovule just developed (11M and 11N)
The active tissue chemical analysis of GUS.Ruler item: B-D, 1mm;E-N, 0.1mm.
Figure 12 shows DA1 and directly interacts in vitro with DA2.By GST-DA1, GST-DA1R358K, GST-DA1-
UIM, GST-DA1-LIM, GST-DA1-LIM+C and GST-DA1-C are pulled down by the MBP-DA2 being fixed on amylose resin
Come (PD) and is analyzed using anti-GST antibody by immunoblotting (IB).
Figure 13 shows the schematic diagram of the DA1 containing specific protein domains and its derivative.The DA1 protein of prediction
Including two UIM motifs, single LIM domain and C-terminal region.
Figure 14 shows DA1 and interacts in vivo with DA2.Ben's tobacco (Nicotiana benthamiana) leaf is logical
Cross the Agrobacterium tumefaciens (Agrobacterium that injection possesses 35S:Myc-DA1 and 35S:GFP-DA2 plasmid
Tumefaciens) GV3101 cell is converted.By gross protein GFP-Trap-A immunoprecipitation, and respectively with anti-GFP
Antibody and anti-Myc antibody detect immunoblotting.Myc-DA1 is detected in the GFP-DA2 compound of immunoprecipitation, to indicate
There are physical correlations between DA1 and DA2 in plant.
Figure 15 shows the da2-1 mutation increased organ size of body display.15A shows Col-0, da2-1 and 35S:DA2#1
Petal length (PL), petal width (PW), petal area (PA), sepal area (SA), the carpel length (CL), long stamen of plant
Length (LSL) and short stamen length (SSL).15B shows the 5th leaf area of Col-0, da2-1 and 35S::DA2#1 plant.
15C shows the weight of Col-0, da2-1 and 35S::DA2#1 flower.15D shows the maximum width region of Col-0 and da2-1 petal
In paraxial epidermal cell size.15E shows the size of the palisade cell in the 5th leaf of Col-0 and da2-1.Open flower
(stage 14) is used to measure the size (15A), the weight (C) of flower and the size (15D) of epidermal cell of petal.Numerical value (A-E) is made
To provide relative to the average value ± SE of corresponding wild type numerical value, it is arranged to 100%.Compared to wild type, * *, P < 0.01 (is learned
Raw t is examined).
Figure 16 shows DA1 and DA2 synergistic effect to control seed size.16D show Col-0, da1-ko1, da2-1 and
The petal area of da1-ko1 da2-1 flower.16E shows the maximum of Col-0, da1-ko1, da2-1 and da1-ko1da2-1 petal
The size of paraxial epidermal cell in width regions.16F shows the seed weight of Col-0, eod1-2, da2-1 and eod1-2da2-1
Amount.16G shows the petal area of Col-0, eod1-2, da2-1 and eod1-2da2-1.Open flower (stage 14) is for measuring
The size (16D and 16G) of petal and the size (16E) of epidermal cell.It is worth (16D-G) as relative to corresponding wild type numerical value
Average value ± SE is provided, and is arranged to 100%.Compared to wild type, * *, P < 0.01 and *, P < 0.05 (student t inspection).Ruler item:
0.1mm。
Figure 17 shows the overexpression limitation organ growth of DA2.17A shows Col-0,35S:DA2#2 and 35S:DA2#4's
Petal area.17B shows the expression of the DA2 in Col-0,35S:DA2#2 and 35S:DA2#4 seedling.It is worth (A and B) conduct
Average value ± SE relative to Col-0 value is provided, and is arranged to 100%.Compared to wild type, * *, P < 0.01 (student t inspection).
Figure 18 shows the overexpression limitation organ growth of DA2L.18A shows Col-0,35S:DA2L#1,35S:DA2L#
3,20 day age plant of 35S:DA2L#4,35S:DA2L#5 and 35S:DA2L#6.18B shows Col-0,35S:DA2L#1,35S:
30 day age plant of DA2L#3,35S:DA2L#4,35S:DA2L#5 and 35S:DA2L#6.18C show Col-0,35S:DA2L#1,
The RT-PCR analysis of DA2L expression in 35S:DA2L#3,35S:DA2L#4,35S:DA2L#5 and 35S:DA2L#6 seedling.To from
First chain cDNA of 2 week old seedling preparation carries out RT-PCR.By cDNA by reference to ACTIN2 standard.Ruler item: A,
1cm, B, 1cm
Figure 19 shows the overexpression limitation seed and organ growth of GW2.19A shows Col-0,35S:GW2#1,35S:
30 day age plant of GW2#2,35S:GW2#3,35S:GW2#6 and 35S:GW2L#7.19B shows Col-0,35S:GW2#1,35S:
The projected area of GW2#2,35S:GW2#3,35S:GW2#6 and 35S:GW2L#7 seed.19C show Col-0,35S:GW2#1,
The quantitative real-time RT-PCR of GW2 gene expression in 35S:GW2#2,35S:GW2#3,35S:GW2#6 and 35S:GW2L#7 seedling
Analysis.Numerical value (B) is provided as the average value ± SE relative to Col-0 numerical value, is arranged to 100%.Compared to wild type, * *, P
< 0.01 (student t inspection).Ruler item: A, 1cm
Specific embodiment
The present invention relates to pass through the expression for changing plant E3 ubiquitin ligase DA2 or active Binding change DA1 and/or EOD1
Expression or activity come change influence yield plant trait (such as seed and organ size) method.Preferably, in plant
Change the expression or activity of DA2 and DA1.
The expression or activity of DA2 can be changed prior to, concurrently with, or after the expression or activity for changing DA1 and/or EOD1.Example
Such as, in some embodiments, the expression or activity of DA2 polypeptide can be changed in one or more plant cells, the plant is thin
Born of the same parents have had following one: the DA1 expression of change or activity, the EOD1 expression of change or activity or the DA1 and EOD1 that change
Expression or activity.
Provided herein is for example increasing the method for the yield of plant by increasing organ or seed size, the method includes
It provides and lacks DA1 and/or EOD1 expression or active plant, and reduce the DA2 in one or more cells of the plant
Expression.In other embodiments, the expression or activity of the DA1 and/or EOD1 in one or more plant cells, institute can be reduced
Plant cell is stated with reduced DA2 polypeptide expression or activity.
Other methods may include the expression of the DA2 in the one or more cells for reduce plant and reduce one or more
The expression or activity of DA1, EOD1 or DA1 and both EOD1 in cell.
The method for generating the plant that there is increased yield relative to wild-type plant is also provided herein, comprising:
(a) the following terms is incorporated in plant cell by converting:
(i) the first heterologous nucleic acids, the nucleic acid reduce the expression of DA2 polypeptide,
(ii) the second heterologous nucleic acids, the nucleic acid reduce the expression of one of DA1 polypeptide and EOD1 polypeptide, and optionally,
(iii) third heterologous nucleic acids, the nucleic acid reduce the expression of the other of DA1 polypeptide and EOD1 polypeptide, and
(b) plant described in the cytothesis from one or more conversion.
Generate the other methods with the plant of increased yield can include:
It provides and lacks DA1 and/or EOD1 expression or activity, the active plant cell of preferably DA1,
The heterologous nucleic acids of the activity of reduction DA2 polypeptide or expression are incorporated in the plant cell by converting, and;
Plant described in cytothesis from the conversion.
After regeneration, it may be selected that there is reduced DA2 polypeptide active or expression and reduction relative to wild-type plant
DA1 and/or EOD1 activity or expression plant.
The combination of reduced DA2 expression and reduced DA1 and/or EOD1 expression cooperates with the seed and/or device for increasing plant
The size of official, to increase plant products.
One of plant or a variety of characters relevant to yield can be expressed by reduced DA2 or activity combines reduction
DA1 and/or EOD1 expression or activity are improved.For example, the control or wild type that can not yet be reduced relative to the expression of DA2 polypeptide
One or more of service life, organ size and the seed size of plant increase plant.
The expression of DA2, DA1 or EOD1 or activity can reduce at least in method described herein relative to wild-type plant
50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95% or at least 98%.In some preferred implementations
In example, expression or activity are reduced to zero or are substantially zero (i.e. expression or activity are eliminated).
The method of the present invention includes the expression or activity of the DA2 polypeptide in the one or more cells for changing plant.
DA2 polypeptide is the E3 ubiquitin ligase found in plant.The DA2 that expression or activity are lowered as described herein
Polypeptide may include RING structural domain (Stone, S.L. et al. (2005)), it is therefore preferable to C5HC2, C5NC2 or C5TC2 RING knot
Structure domain.Suitable RING structural domain can be made of the amino acid sequence of SEQ ID NO:1;
C(X)2C(X)11CC(X)4CX2CX7(H/N/T)X6CX2C。(SEQ ID NO:1)
For example, suitable RING structural domain can be made of the amino acid sequence of SEQ ID NO:2;
CPICFL(Y/F)YPSLNRS(K/R)CC(S/M/T/A)K(G/S)ICTECFL(Q/R)MK(P/N/S/V/T/N)
(T/P)(H/N/T)(T/S)(A/T/C)(R/Q/K)PTQCP(F/Y)C
(SEQ ID NO:2)
In some embodiments, the H/N/T residue at the position 33 in the RING structural domain of SEQ ID NO:2 can be T
Or N.
In some preferred embodiments, DA2 polypeptide may include RING structural domain, and the RING structural domain has in table 1
Shown in amino acid sequence (SEQ ID NO:3-19), such as arabidopsis DA2 (SEQ ID NO:11), arabidopsis DAL2 (SEQ
ID NO:13) or rice GW2 (SEQ ID NO:7) or its variant.For example, RING structural domain can have the amino acid of the following terms
Sequence: residue 59 to 101, the SEQ ID NO:21 (Rc_GI- of SEQ ID NO:20 (Pt_GI-224061326.pro)
The residue 59 to 101 of residue 59 to 101, SEQ ID NO:22 (Vv_GI-147817790.pro) 255578534.pro),
Residue 59 to 101, the SEQ ID NO:24 (At_GI- of SEQ ID NO:23 (Gm_GI-356549538.pro)
Residue 61 to 103, the SEQ of residue 59 to 101, SEQ ID NO:25 (Ta_GI 408743661.pro) 18411948.pro)
Residue 61 to 103, the SEQ ID NO:27 (Bd_GI-357140854.pro) of ID NO:26 (Hv_GI-164371454.pro)
Residue 61 to 103, SEQ ID NO:28 (Os_GI-115445269.pro) residue 62 to 104, SEQ ID NO:29 (Sb_
GI-242064618.pro the residue 65 of residue 63 to 105, SEQ ID NO:30 (Zm_GI-220961719.pro)) to
107, the residue 61 to 103 of SEQ ID NO:31 (Ta_GI-408743658.pro), SEQ ID NO:32 (Bd_GI-
Residue 62 to 104, the SEQ of residue 43 to 85, SEQ ID NO:33 (Os_GI-218197613.pro) 357125256.pro)
The residue 62 to 104 or SEQ ID NO:35 (Sb_GI-242092026.pro) of ID NO:34 (Zm_GI-260935347.pro)
Residue 62 to 104.
Other suitable RING domain sequences can be used standard sequence analysis technology as described herein (for example, simple
Module tectonic cycle period tool (SMART);EMBL Heidelberg, DE) identify.
DA2 polypeptide may also include the first apokoinou construction domain.First apokoinou construction domain can be located at the upstream of RING structural domain (i.e.
In N-terminal side).The first suitable apokoinou construction domain can be made of the amino acid sequence of SEQ ID NO:36.
Q (Q/ is not present) GLY (P/M/N/V/Q/L/V/E) (H/S/N) (P/K/R) D (I/V) D (L/I/H/V/Q) (K/R)
KL
(R/K)(R/K)LI(V/L)(E/D)(A/S/T)KLAPC
(SEQ ID NO:36)
In some preferred embodiments, DA2 polypeptide may include the first shared of DA2 amino acid sequence shown in table 2
Structural domain, such as the residue 20 to 45 of SEQ ID NO:20, the residue 20 to 45 of SEQ ID NO:21, SEQ ID NO:22's are residual
Base 20 to 45, the residue 20 to 45 of SEQ ID NO:23, the residue 20 to 45 of SEQ ID NO:24, SEQ ID NO:25 residue
21 to 46, the residue 21 of the residue 21 to 46 of SEQ ID NO:26, the residue 21 to 46 of SEQ ID NO:27, SEQ ID NO:28
To the 46, residue 21 to 46 of SEQ ID NO:29, the residue 21 to 46 of SEQ ID NO:30, SEQ ID NO:31 residue 21 to
46, the residue 23 to 48 of the residue 4 to 29 of SEQ ID NO:32, the residue 23 to 48 of SEQ ID NO:33, SEQ ID NO:34
Or the residue 23 to 48 of SEQ ID NO:35.
DA2 polypeptide may also include the second apokoinou construction domain.Second apokoinou construction domain can be located at the downstream of RING structural domain (i.e.
On C-terminal side).Second apokoinou construction domain can be made of the amino acid sequence of SEQ ID NO:37.
(N/S)YAVEYRG(V/G)K(T/S)KEE(K/R)(G/S)(V/T/I/F/L/M)EQ(L/I/V/F)EEQ(R/L/
K)VIEA(Q/K)(I/M)RMR(H/Q)(K/Q)(E/A)
(SEQ ID NO:37)。
In some preferred embodiments, DA2 polypeptide may include the second shared of DA2 amino acid sequence shown in table 2
Structural domain, such as the residue 106 to 141 of SEQ ID NO:20, the residue 106 to 141 of SEQ ID NO:21, SEQ ID NO:22
Residue 106 to 141, the residue 106 to 141 of SEQ ID NO:23, the residue 106 to 141 of SEQ ID NO:24, SEQ ID
The residue 107 to 143 of NO:25, the residue 107 to 143 of SEQ ID NO:26, SEQ ID NO:27 residue 107 to 143, SEQ
The residue 108 to 144 of ID NO:28, the residue 109 to 145 of SEQ ID NO:29, SEQ ID NO:30 residue 111 to 147,
The residue 107 to 143 of SEQ ID NO:31, the residue 90 to 125 of SEQ ID NO:32, SEQ ID NO:33 residue 108 to
143, the residue 108 to 143 of the residue 108 to 143 of SEQ ID NO:34 or SEQ ID NO:35.
Standard sequence analysis skill as described herein can be used in other examples of the first and second suitable domain sequences
Art is (for example, simple module tectonic cycle period tool (SMART);EMBL Heidelberg, DE) identify.
In some preferred embodiments, the DA2 polypeptide that expression or activity are lowered as described herein may include SEQ
Second shared knot of the RING structural domain of ID NO:2, the first apokoinou construction domain of SEQ ID NO:36 and SEQ ID NO:37
Structure domain.
For example, DA2 polypeptide may include RING domain sequence listed above, the first apokoinou construction domain sequence and second
Any combination of apokoinou construction domain sequence.
Suitable DA2 polypeptide may include the amino acid sequence such as any of the SEQ ID NO 20 to 35 that lists in table 2
Or it can be one variant in these sequences.In some preferred embodiments, DA2 polypeptide may include SEQ ID NO:28
Or 33 (OsGW2) amino acid sequence, SEQ ID NO:24 (AtDA2), SEQ ID NO:25 or SEQ ID NO:31 (TaGW2)
Or the variant that any of can be these sequences with E3 ubiquitin ligase activity.
For SEQ ID NO:20 to any of 35 or other with reference to DA2 sequence variant DA2 polypeptides may include with
It is described with reference to DA2 sequence have at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least
80%, the amino acid sequence of at least 90%, at least 95% or at least 98% sequence identity.
DA2 polypeptide for the variant of SEQ ID NO:20 to any of 35 may also include the sequence with SEQ ID NO:2
The RING structural domain of column, the first apokoinou construction domain of sequence with SEQ ID NO:36 and the sequence with SEQ ID NO:37
Second apokoinou construction domain of column.The example of suitable sequence is as listed above out.In some preferred embodiments, DA2 polypeptide can
RING structural domain, the first apokoinou construction domain and the second apokoinou construction domain including SEQ ID NO:20 to any of 35.
The nucleic acid of encoding D A2 polypeptide may include selected from by JN896622.1 GI:408743658 (TaGW2-A);With
The nucleotide sequence listed or can be in the data base entries of the group of JN896623.1 GI:408743660 (TaGW2-B) composition
It is one variant in these sequences.
In some preferred embodiments, the nucleic acid of encoding D A2 polypeptide may include coding AtDA2, AtDAL2, OsGW2,
The nucleotide sequence of TaGW2-A or TaGW2-B or the variant that any of can be these DA2 sequences, coding have DA2
Active polypeptide.
DA2 polypeptide and code nucleic acid, institute can be identified using routine sequence analysis technology in any target plant species
Plant species specifically crop is stated, such as wheat, barley, corn, rice, soybean;And other agricultural plant.
DA2 expression or active reduction show the prominent of the activity or expression for cooperateing with enhancing to reduce DA1 herein in plant
Become the effect to the Correlated Yield Characters in plant.In a preferred embodiment, method described herein may include reducing to lack
Both DA2 expression in DA1 expression or active plant or the DA1 in reduction plant and DA2 expression.
DA1 polypeptide be the ubiquitin receptor found in plant and in Li et al. people (2008), Wang et al. (2012) and
It is described in detail in WO2009/047525.The DA1 polypeptide that expression or activity are lowered as described herein may include LIM domain, protect
The C-terminal structural domain and one or more UIM structural domain kept.
LIM domain includes two Zn zinc-finger motifs and can have amino acid sequence (SEQ ID NO:38);
C(X)2 C(X)16-23 (H/C)(X)2/4 (C/H/E)(X)2 C(X)2 C(X)14-21 (C/H)(X)2/1/3 (C/H/D/E)X
Wherein X is any amino acid and Zn coordination residue underlines.
Zn coordination residue in LIM domain can be C, H, D or E, preferably C.
In some preferred embodiments, LIM domain may include CXXC, HXXCXXCXXC and HxxC motif, and wherein X is
Any amino acid.For example, LIM domain may include amino acid sequence (SEQ ID NO:39);
C(X)2 C(X)16-23 (H)(X)2 (C)(X)2 C(X)2 C(X)14-21 H(X)2 CX
Wherein X is any amino acid and Zn coordination residue underlines.
In some embodiments, LIM domain may include the amino acid sequence of AtDA1 LIM domain;
CAGCNMEIGHGRFLNCLNSLWHPECFRCYGCSQPISEYEFSTSGNYPFHKACY
(SEQ ID NO:40;Zn coordination residue underlines)
Other LIM domains include the LIM domain of DA1 amino acid sequence shown in table 3, such as SEQ ID NO:41
(Si_GI-514815267.pro) residue of residue 141 to 193, SEQ ID NO:42 (Bd_GI-357157184.pro)
123 to 175, the residue 155 to 207 of SEQ ID NO:43 (Br_DA1b.pro), SEQ ID NO:44 (Br_DA1a.pro)
Residue 172 to 224, the residue 172 to 224 of SEQ ID NO:45 (At_GI-15221983.pro), SEQ ID NO:46 (Tc_
GI-508722773.pro the residue 117 of residue 117 to 169, SEQ ID NO:47 (Gm_GI-356564241.pro)) to
169, the residue 121 to 173 of SEQ ID NO:48 (Gm_GI-356552145.pro), SEQ ID NO:49 (Vv_GI-
The residue 122 to 174 of residue 119 to 171, SEQ ID NO:50 (Vv_GI-359492104.pro) 302142429.pro),
Residue 125 to 177, the SEQ ID NO:52 (Os_GI- of SEQ ID NO:51 (Sl_GI-460385048.pro)
The residue 124 to 176 of residue 516 to 568, SEQ ID NO:53 (Os_GI-115466772.pro) 218197709.pro),
Residue 150 to 202, the SEQ ID NO:55 (Bd_GI- of SEQ ID NO:54 (Bd_GI-357160893.pro)
The residue 124 to 176 of residue 132 to 184, SEQ ID NO:56 (Sb_GI-242092232.pro) 357164660.pro),
Residue 147 to 199, the SEQ ID NO:58 (At_GI- of SEQ ID NO:57 (Zm_GI-212275448.pro)
The residue 162 to 214 of residue 190 to 242, SEQ ID NO:59 (At_GI-145360806.pro) 240256211.pro),
Residue 1240 to 1291, the SEQ ID NO:61 (At_GI- of SEQ ID NO:60 (At_GI-22326876.pro)
Residue 347 to 402, the SEQ of residue 80 to 122, SEQ ID NO:62 (At_GI-30698240.pro) 30698242.pro)
Residue 286 to 341, the SEQ ID NO:64 (At_GI-334188680.pro) of ID NO:63 (At_GI-15240018.pro)
Residue 202 to 252.
LIM domain sequence can be used standard sequence analysis technology (for example, simple module tectonic cycle period tool (SMART);
EMBL Heidelberg, DE) identify.
In addition to LIM domain, DA1 albumen may also include carboxy-terminal end region, the carboxy-terminal end region have with it is following
Every sequence at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least
90%, the amino acid sequence of at least 95% or at least 98% amino acid identities: the residue 198 to 504 of SEQ ID NO:41,
The residue 180 to 487 of SEQ ID NO:42, the residue 212 to 514 of SEQ ID NO:43, SEQ ID NO:44 residue 229 to
532, the residue of the residue 229 to 532 of SEQ ID NO:45, the residue 174 to 478 of SEQ ID NO:46, SEQ ID NO:47
174 to 474, the residue 178 to 478 of SEQ ID NO:48, the residue 176 to 462 of SEQ ID NO:49, SEQ ID NO:50
Residue 179 to 482, the residue 182 to 486 of SEQ ID NO:51, the residue 573 to 878 of SEQ ID NO:52, SEQ ID NO:
53 residue 181 to 486, the residue 207 to 512 of SEQ ID NO:54, the residue 189 to 491 of SEQ ID NO:55, SEQ ID
The residue 181 to 486 of NO:56, the residue 204 to 508 of SEQ ID NO:57, SEQ ID NO:58 residue 247 to 553, SEQ
The residue 219 to 528 of ID NO:59, the residue 1296 to 1613 of SEQ ID NO:60, SEQ ID NO:61 residue 128 to
450, the residue of the residue 404 to 702 of SEQ ID NO:62, the residue 343 to 644 of SEQ ID NO:63, SEQ ID NO:64
256 to 587.
The carboxy-terminal end region of DA1 albumen may include metallopeptidase motif HEMMH (SEQ ID NO:65).
Carboxy-terminal end region may also include the EK (X) between LIM domain and HEMMH motif8R(X)4SEEQ(SEQ
ID NO:66) or EK (X)8R(X)4SEQ (SEQ ID NO:67) motif.
Other than LIM domain and conservative carboxy-terminal end region, DA1 albumen may include UIM1 structural domain and UIM2 knot
Structure domain.UIM1 and UIM2 structural domain can be located between the N-terminal and LIM domain of DA1 albumen.
UIM1 structural domain can be made of the sequence of SEQ ID NO:68 and UIM2 structural domain can be by SEQ ID NO:69's
Sequence composition.
p---pLpbAl pb.Sbp-.pp p(SEQ ID NO:68)
p---pLpbAl pb.Sbp-spp p(SEQ ID NO:69)
Wherein;
P is polar amino acid residues, for example, C, D, E, H, K, N, Q, R, S or T;
B is big amino acid residue, for example, E, F, H, I, K, L, M, Q, R, W or Y;
S is p1 amino acid residue, for example, A, C, D, G, N, P, S, T or V;
L is aliphatic amino acid residue, such as I, L or V;
Be be not present or any amino acid, and
It is any amino acid.
Standard sequence analysis technology (example as described herein can be used in other examples of UIM1 and UIM2 domain sequence
Such as, simple module tectonic cycle period tool (SMART);EMBL Heidelberg, DE) identify.
In some preferred embodiments, DA1 polypeptide may include;
The LIM domain of SEQ ID NO:39,
C-terminal region, the residue 229 to 532 or SEQ NO 41 to 44 of the C-terminal region and SEQ ID NO:45 or
The equivalent area of any one in 46 to 64 has at least 20% sequence identity, such as listed above and including EK (X)8R(X)4SEEQ or EK (X)8R(X)4SEQ motif and HEMMH motif,
The UIM structural domain of SEQ ID NO:66, and
The UIM structural domain of SEQ ID NO:67.
DA1 albumen may include plant DA1 albumen shown in table 3 amino acid sequence (SEQ ID NO:41 to 64) or can
To be one homologue or variant in these sequences, the homologue or variant have DA1 activity.For example, DA1 polypeptide can
Including amino acid sequence shown in table 3 (SEQ ID NO:41 to 64) or it can be one variant in these sequences, institute
Variant is stated with DA1 activity.
For example, DA1 polypeptide may include AtDA1, AtDAR1, AtDAR2, AtDAR3, AtDAR4, AtDAR5, AtDAR6,
AtDAR7、BrDA1a、BrDA1b、BrDAR1、BrDAR2、BrDAR3-7、BrDAL1、BrDAL2、BrDAL3、OsDA1、
OsDAR2、OsDAL3、OsDAL5、PpDAL1、PpDAL2、PpDAL3、PpDAL4、PpDAL5、PpDAL6、PpDAL7、PpDAL8、
The amino acid sequence of SmDAL1, SmDAL2 or ZmDA1, preferably AtDA1, AtDAR1, BrDA1a, BrDA1b, OsDA1 or
One homologue or variant in the amino acid sequence of ZmDA1 or these sequences.
In some preferred embodiments, DA1 polypeptide may include AtDA1 (AT1G19270;NP_173361.1GI:
15221983) amino acid sequence or the variant that can be this sequence, the variant have DA1 activity.
Standard sequence analysis tool can be used to reflect for other DA1 protein sequences including the above-mentioned characteristic features listed
Not.Technical staff can easily identify the nucleic acid sequence of the encoding D A1 albumen in any target plant species.
DA1 albumen in target plant species can have for the variant for the DA1 albumen reference amino acid sequence listed herein
Amino acid sequence.
For with reference to DA1 sequence variant DA1 polypeptide, such as any of SEQ ID NO 41 to 64, it may include with institute
State reference sequences at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%,
The amino acid sequence of at least 90%, at least 95% or at least 98% sequence identity.
The specific amino acid sequence variation occurred in plant species can exist with the reference sequences difference listed herein
In 1 amino acid, 2,3,4,5-10,10-20,20-30,30-50 or the insertion more than 50 amino acid, addition, substitution or lack
It loses.
In some embodiments, the DA1 polypeptide for the variant of the AtDA1 sequence of SEQ ID NO:45 may include with sequence
The UIM1 structural domain of QENEDIDRAIALSLLEENQE (SEQ ID NO:70) and have sequence D EDEQIARALQESMVVGNSP
The UIM2 structural domain of (SEQ ID NO:71).
DA1 polypeptide for the variant of the AtDA1 sequence of SEQ ID NO:45 may include having following sequence of LIM structure
Domain:
ICAGCNMEIGHGRFLNCLNSLWHPECFRCYGCSQPISEYEFSTSGNYPFHKAC
(SEQ ID NO:72)
The nucleic acid of encoding D A1 polypeptide may include selected from by NM_101785.3GI:42562170 (AtDA1);NM_
001057237.1GI:115454202(OsDA1);The database of the group of BT085014.1GI:238008663 (ZmDA1) composition
The nucleotide sequence listed in entry can be one variant in these sequences, the variant encoding active DA1 polypeptide.
In some preferred embodiments, the nucleic acid of encoding D A1 polypeptide may include AtDA1 (NM_101785.3GI:
42562170), the core of ZmDA1 (BT085014.1GI:238008663), OsDA1 (NM_001057237.1GI:115454202)
Nucleotide sequence or the variant that any of can be these sequences, coding retain the active polypeptide of DA1.
DA1 polypeptide and code nucleic acid, the plant object can be identified using routine sequence analysis technology in plant species
Kind specifically crop, such as wheat, barley, corn, rice and other agricultural plant.
In some preferred embodiments, the DA1 activity in one or more cells of plant can be by one
Or dominant negative DA1 polypeptide is expressed in multiple cells to reduce (see, for example, Li et al. people (2008);WO2009/047525;
Wang et al. is 2012).The plant for expressing dominant negative DA1 polypeptide can have da1-1 phenotype.
The dominant negative allele of DA1 polypeptide may include that there is mutation (such as to replace or lack at conservative R residue
Lose) DA1 polypeptide, the R residue is located at the position of the position 358 of arabidopsis DA1 amino acid sequence, corn DA1 amino acid sequence
It sets at the equivalent position in 333 or another kind DA1 amino acid sequence.For example, the dominant negative allele of DA1 polypeptide may include
Guarantor at the position of the position 333 of the position 358 or corn DA1 amino acid sequence that are equivalent to arabidopsis DA1 amino acid sequence
Keep the mutation of R residue.In a preferred embodiment, conservative R residue can be replaced by K.
The position 358 of the SEQ ID NO:45 for being equivalent to arabidopsis DA1 in DA1 amino acid sequence or SEQ ID
Conservative R residue at the position of the position 333 of the corn DA1 of NO:57 is located in DA1 amino acid sequence and corresponds to SEQ ID
At the position of the R358 of the R333 and SEQ ID NO:45 of NO:57, i.e., it is in other motifs and structural domain relative to DA1 albumen
Same position in.Conservative R residue is located between the LIM domain in C-terminal region and HEMMH peptase motif, and in DA1
It is completely conservative under same sequence background in albumen.Conservative R residue may include the EK (X) in C-terminal region8R(X)4SEEQ (SEQ ID NO:66) or EK (X)8R(X)4In SEQ (SEQ ID NO:67) motif.
Conservative R residue can compare these conservative C-terminal regions by using standard sequence analysis and comparison tool
And identifies and use arrow logo in the sequence of table 3.
The nucleic acid of the dominant negative allele of encoding D A albumen can be generated by any convenient technology.For example, can
Site directed mutation is used on the nucleic acid of encoding D A1 polypeptide to change in the R333 with the R358 of arabidopsis DA1 or corn DA1
Conservative R residue at equivalent position, such as change into K.Reagent and kit for being mutated in vitro are commercially available.
In some embodiments, the nucleic acid for encoding dominant negative DA1 polypeptide as described herein can operationally connect
It is connected to heterologous regulatory sequence, such as promoter, such as composing type, induction type, tissue specificity or development-specific promoter.Coding
The nucleic acid of dominant negative DA1 polypeptide may include in one or more carriers.For example, the dominant negative etc. of encoding D A1 albumen
The nucleic acid of the mutation of position gene can also be cloned into expression vector and be expressed in plant cell as described below to change and plant
Object phenotype.
In other embodiments, in the endogenous DA1 nucleic acid that mutation can be introduced in plant, so that by mutant DA1
The DA1 polypeptide of nucleic acid encode has dominant negative activity.
The nucleic acid of the DA1 polypeptide of encoding dominant negative feminine gender can its initial separation from identical plant species or mutation in table
It reaches or is expressed in different plant species or mutation (i.e. heterologous plant).
What DA2 was expressed in plant reduces or eliminates in the expression or active mutation pair for also showing enhancing reduction EOD1 herein
The effect of Correlated Yield Characters in plant.
Method described herein may include the DA2 expression reduced lack in EOD1 expression or active plant or activity or drop
The expression or activity of DA2 and both EOD1 in low plant.In a preferred embodiment, plant can also lack DA1 activity or institute
Stating method in addition may include the DA1 expression reduced or eliminated in the plant.
EOD1 polypeptide is the E3 ubiquitin ligase found in plant and in Disch et al. (2006), Li et al. people
(2008) and in WO2009/047525 it is described in detail.
The EOD1 polypeptide that expression or activity are lowered as described herein may include EOD structural domain.Suitable EOD structural domain
It can be made of the amino acid sequence of SEQ ID NO:73;
(E/K)RCVICQ(L/M)(K/R/G/T/E)Y(K/R)(R/I)(G/K)(D/N/E)(R/Q/K/L)Q(I/M/V)
(K/N/T/A)L(L/P)C(K/S)H(V/A)YH(S/T/G/A)(E/Q/D/S/G)C(I/G/T/V)(S/T)(K/R)WL(G/T/
S)INK(V/I/A/K)CP(V/I)C(SEQ ID NO:73)
In some preferred embodiments, EOD1 polypeptide may include the EOD structure with the amino acid sequence of the following terms
Domain: residue 195 to 237, the SEQ ID NO:75 (Sb_GI- of SEQ ID NO:74 (Zm_GI-223973923.pro)
The residue 195 to 237 of residue 195 to 237, SEQ ID NO:76 (Zm_GI-226496789.pro) 242042045.pro),
Residue 218 to 260, the SEQ ID NO:78 (Os_GI- of SEQ ID NO:77 (Os_GI-222624282.pro)
The residue 197 to 239 of residue 196 to 238, SEQ ID NO:79 (Bd_GI-357113826.pro) 115451045.pro),
Residue 193 to 235, the SEQ ID NO:81 (Rc_GI- of SEQ ID NO:80 (Sl_GI-460410949.pro)
The residue 150 to 192 of residue 187 to 229, SEQ ID NO:82 (Pt_GI-224059640.pro) 255582236.pro),
Residue 194 to 236, the SEQ ID NO:84 (Gm_GI- of SEQ ID NO:83 (Gm_GI-356548935.pro)
The residue 194 to 236 of residue 194 to 236, SEQ ID NO:85 (Vv_GI-359487286.pro) 356544176.pro),
Residue 189 to 231, the SEQ ID NO:87 (Pp_GI- of SEQ ID NO:86 (Tc_GI-508704801.pro)
The residue 190 to 232 of residue 192 to 234, SEQ ID NO:88 (Cr_GI-482561003.pro) 462414664.pro),
The residue 195 to 237 of SEQ ID NO:89 (At_GI-22331928.pro) or the residue 195 to 237 of SEQ ID NO:90
(Sl_GI-460370551.pro), as shown in table 4.
Other suitable EOD domain sequences can be used standard sequence analysis technology as described herein (for example, simple mould
Block tectonic cycle period tool (SMART);EMBL Heidelberg, DE) identify.
The EOD1 polypeptide that expression or activity are lowered as described herein may include SEQ ID NO as listed in Table 4
Any of 74 to 90 amino acid sequence.In some preferred embodiments, EOD1 polypeptide may include SEQ ID NO:89
(AtEOD1) or the amino acid sequence of SEQ ID NO:77 or 78 (OsEOD1) or the variant that can be this sequence it is general, to retain E3
Element connection enzymatic activity.
May include for SEQ ID NO:74 to any of 90 or other EOD1 polypeptides for referring to the variant of EOD1 sequence
With it is described with reference to EOD1 sequence have at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%,
The amino acid sequence of at least 80%, at least 90%, at least 95% or at least 98% sequence identity.
It may also include for the EOD polypeptide of the variant of SEQ ID NO:74 to any of 90 with SEQ ID NO:73's
The EOD structural domain of sequence.The example of suitable sequence is as listed above out.
The nucleic acid for encoding EOD1 polypeptide may include the core listed in the data base entries selected from the group being made of the following terms
Nucleotide sequence: XM_002299911.1GI:224059639 (PtEOD1);XM_002531864.1GI:255582235
(RcEOD1);XM_002279758.2GI:359487285(VvEOD1);XM_003542806.1GI:356548934
(GmEOD1a);XM_003540482.1GI:356544175(GmEOD1b);XM_002468372.1GI:242042044
(SbEOD1);NM_001147247.1GI:226496788(ZmEOD1);Or NP_001030922.1GI:79316205
(AtEOD1;At3g63530), or it can be one variant in these sequences.
In some preferred embodiments, the nucleic acid of coding EOD1 polypeptide may include the nucleosides for encoding AtEOD1 or OsEOD1
Acid sequence or the variant that any of can be these sequences, the variant coding have the active polypeptide of EOD1.
Expression can be identified using routine sequence analysis technology in any target plant species or activity is as described herein
The EOD1 polypeptide and code nucleic acid being lowered, the plant species specifically crop, such as wheat, barley, corn, rice, big
Beans;And other agricultural plant.
DA2 mutation in plant is also showing the combination of collaboration enhancing DA1 and EOD1 mutation to the yield in plant herein
The effect of correlated traits.
Method described herein is not limited to specific plant species, and DA2, DA1 and/or EOD1 expression or activity can
It is reduced in any target plant species, as described herein.
DA1, DA2 or EOD1 polypeptide in target plant species can have correspondence DA1, DA2 or EOD1 to list herein
The amino acid sequence of the variant of reference amino acid sequence.DA1, DA2 or EOD1 for the variant for the reference sequences listed herein is more
Peptide may include with the reference sequences have at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least
70%, the amino acid sequence of at least 80%, at least 90%, at least 95% or at least 98% sequence identity.
The specific amino acid sequence variation occurred in plant species can exist with the reference sequences difference listed herein
In 1 amino acid, 2,3,4,5-10,10-20,20-30,30-50 or the insertion more than 50 amino acid, addition, substitution or lack
It loses.
DA1, DA2 or EOD1 nucleic acid in target plant species can have correspondence DA1, DA2 or EOD1 to list herein
The nucleotide sequence of the variant of reference nucleotide sequence.For example, Variant nucleotide sequences can be the reference DA1 listed herein,
The homologue or allele of DA2 or EOD1 sequence, and can be with the difference with reference to DA1, DA2 or EOD1 nucleotide sequence
Place be one or more of nucleic acid (such as 2,3,4,5-10,10-20,20-30,30-50 or more than 50) nucleotide
Addition, one or more of insertion, deletion or substitution, add so as to cause one or more amino acid in the polypeptide of coding
Add, insertion, deletion or substitution.Certainly, the variation on the amino acid sequence of coding without influence including being carried out on nucleic acid.DA1,
DA2 or EOD1 code nucleic acid may include the sequence for having at least 20% or at least 30% sequence identity with reference nucleic acid sequence,
Preferably at least 40%, at least 50%, at least 60%, at least 65%, at least 70%, at least 80%, at least 90%, at least 95% or
At least 98%.Sequence identity is in above description.
Sequence similarity and identity are typically referenced to algorithm GAP (Wisconsin Package, Accelerys, San
Diego USA) Lai Dingyi.GAP compares two complete sequences using Needleman and Wunsch algorithm, and the algorithm makes
The number matched maximizes and minimizes the number in vacancy.In general, using default parameter, wherein gap creation penalty=12 Hes
Gap extension penalties=4.It the use of GAP may be preferred, but other algorithms can also be used, such as (it is used BLAST
The method of Altschul et al. (1990) J.Mol.Biol.215:405-410), FASTA (its use Pearson and Lipman
(1988) method of PNAS USA 85:2444-2448) or Smith-Waterman algorithm (Smith and Waterman (1981)
J.Mol Biol.147:195-197) or TBLASTN program for being same as above of Altschul et al. (1990), generally use default ginseng
Number.Specifically, psi-Blast algorithm (Nucl.Acids Res. (1997) 253389-3402) can be used.
Sequence, which compares, to be carried out in the overall length of correlated series as described herein.
Suitable variant amino acids and nucleotide sequence can be used standard sequence analysis technology in any target plant species
Middle identification.
For DA1, DA2 or EOD1 nucleotide sequence of the variant for reference DA1, DA2 or EOD1 nucleic acid sequence listed herein
Can selectively it hybridize with the nucleic acid sequence or its complement under strict conditions.
Stringent condition includes for example, being the identical sequence of about 80%-90% for hybridization, in 0.25M at 42 DEG C
Na2HPO4In (pH 7.2), 6.5%SDS, 10% dextran sulfate hybridized overnight and at 55 DEG C in 0.1X SSC, 0.1%SDS
In finally wash.For being detected as greater than about 90% identical sequence, suitable condition is included at 65 DEG C in 0.25M
Na2HPO4, pH 7.2,6.5%SDS, in 10% dextran sulfate hybridized overnight and at 60 DEG C in 0.1X SSC, 0.1%SDS
In finally wash.
In plant nucleic acid preparation may particularly suitable alternative solution be 5x SSPE (final 0.9M NaCl,
0.05M sodium phosphate, 0.005M EDTA pH 7.7), 5X step on the solution of Ha Teshi solution, 0.5%SDS, at 50 DEG C or 65 DEG C
Overnight.As needed, washing can carry out or at 50 DEG C -60 DEG C in 0.2x SSC/0.1%SDS in 1x SSC/ at 65 DEG C
It is carried out in 0.1%SDS.
Nucleic acid as described herein can be wholly or partially synthetic.Especially, they can be recombination, be not
The nucleic acid sequence (discontinuous extend) found together in nature has been connected or artificial combination in another way.Alternatively, it
May directly be synthesized, such as use automatic synthesizer.
The expression of DA2 nucleic acid and DA1 and/or EOD1 nucleic acid can by any convenient technology plant one or more
It is reduced or eliminated in cell.
It is in this field for reducing the expression or active method of DA2 polypeptide and DA1 and/or EOD1 polypeptide in plant
It is well known and be described more fully hereinafter in.In some embodiments, the expression of active DA2, DA1 and/or EOD1 polypeptide can
By will be reduced in the nucleic acid sequence being mutated in introduced plant cell, preferably eliminate, it is described in the nucleic acid sequence encoding more
The expression of peptide or the regulation nucleic acid sequence.The mutation can destroy the expression or function of DA2, DA1 and/or EOD1 polypeptide.It is suitable
The mutation of conjunction includes knocking out and striking low mutation.In some embodiments, mutation can produce the dominant negative allele of DA1.So
It afterwards can be from the cytothesis plant of the mutation.Nucleic acid can be mutated by being inserted into or lacking one or more nucleotide.For
The technology of mutation, inactivation or knockout target gene is well known in the art (see, for example, In Vitro Mutagenesis
Protocols;Methods in Molecular Biology (second edition) Ed Jeff Braman;Sambrook J et al.
2012.Molecular Cloning:A Laboratory Manual (the 4th edition) CSH Press;Current Protocols
in Molecular Biology;Ed Ausubel et al. (2013) Wiley).In some embodiments, it can be compiled by genome
Mutation is introduced in target EOD1, DA2 or DA1 gene by the technology of collecting, such as RNA guides nucleic acid zymotechnic such as CRISPR, zinc finger core
Sour enzyme (ZFN) and transcriptional activators sample effector nuclease (TALEN) (Urnov, F.D. et al. Nature
reviews.Genetics 11,636-646(2010);Joung, J.K. et al. Nature reviews.Molecular cell
biology 14,49-55(2013);Gasiunas, G. et al. PNAS USA 109, E2579-2586 (2012);Cong, L. etc.
People Science 339,819-823 (2013)).
It reduces expression or active series jump may include one or more nucleotide relative to wild-type nucleotide sequences
Missing, insertion or substitution, gene magnification or methylation such as supermethylation increase or decrease.One or more of mutation
It can be in the coding or noncoding region of nucleic acid sequence.Mutation in the code area of the gene of encoder element can prevent overall length living
Property protein translation, i.e. truncated mutant, or allow overall length but the translation of inactive or impaired functional protein, i.e., missense is prominent
Become.Mutation or epigenetic variation such as methylation in the noncoding region of the gene of encoder element, such as in controlling element can be prevented
The only transcription of the gene.Nucleic acid including one or more series jumps can be compiled for example by the activity of the change of controlling element
There is code active variant polypeptide or codified reduce or elimination to have seldom or without expression wild type more in the cell
Peptide.Nucleic acid including one or more series jumps can relative to unmutated sequence have one, two, three, four or
More mutation.
For example, can by corresponding to SEQ ID NO:89 position 44 position at introduce mutation as missing, insertion or
Replace, for example, A to T replaces, to reduce, preferably eliminate the activity of EOD1.SEQ ID NO is equivalent in EOD1 polypeptide sequence:
Standard sequence analysis and comparison tool can be used to identify for the position of 89 position 44, as shown in table 4.
Standard sequence analysis technology can be used, such as by planting compared with the reference sequences listed herein in any target
Identify DA2, DA1 and EOD1 coded sequence in object species.
The mutation of expression suitable for elimination activity DA2, DA1 and/or EOD1 polypeptide will be aobvious and easy for technical staff
See.
In some preferred embodiments, it can will reduce or eliminate DA2 expression or active mutation is introduced to plant cell
In, the plant cell expresses dominant negative DA1 polypeptide and optionally includes the heterologous core for i) encoding EOD1 repressor nucleic acid
Acid or ii) reduce EOD1 expression or active mutation.
It in some embodiments, can be by being reduced in the plant cell in the cell inner expression heterologous nucleic acids of plant
The expression of DA1, DA2 and/or EOD1 polypeptide, heterologous nucleic acids coding or Transcription inhibition daughter nucleus acid, for example, repressor RNA or
RNAi molecule.Repressor RNA inhibits the expression of its target polypeptide (i.e. DA1, DA2 or EOD1) in plant cell.
Nucleic acid as described herein can be wholly or partially synthetic.Specifically, they can be recombination, it is
The nucleic acid sequence (discontinuous extend) not found together in nature has been connected or artificial combination in another way.Alternatively,
They may directly have been synthesized, such as use automatic synthesizer.
Nucleic acid can of course be double-strand or single-stranded, cDNA or genomic DNA or RNA.Depending on design, nucleic acid be can be
Wholly or partially synthetic.In general, technical staff will be appreciated that when nucleic acid includes RNA, referring to for the sequence to shown in should be solved
It is interpreted as referring to that wherein U is replaced by T to RNA equivalent.
" heterologous " instruction is the base for intervening the nucleotide that will be discussed by people using genetically engineered or recombination method
Gene/sequence sequence that cause/sequence or regulation are discussed is introduced in the cell of plant or its ancestors.To plant cell
For heterologous nucleotide sequence can be it is non-naturally occurring in the cell of the type, mutation or species (that is, exogenous
Or it is external) or can be in the subcellular of the cell or genomic context non-naturally occurring sequence or can be with
It is the sequence that non-natural regulates and controls in the cell, be connected to non-natural controlling element with can be operated.
It is well known in the art for inhibiting the expression of the target polypeptide in plant cell.Suitable repressor nucleic acid can be phase
For DA1, DA2 and/or EOD1 gene with target DA1, DA2 and/or EOD1 gene of antisense or ariyoshi orientation or both insertion
All or part of copy, so as to realize the target gene expression reduction.See, for example, van der Krol et al.,
(1990)The Plant Cell 2,291-299;Napoli et al., (1990) The Plant Cell 2,279-289;
Zhang et al., (1992) The Plant Cell 4,1575-1588 and US-A-5,231,020.The other improvements of the method
It can be at WO95/34668 (Biosource);Angell&Baulcombe(1997)The EMBO Journal 16,12:3675-
3684;And it is found in Voinnet&Baulcombe (1997) page Nature389: the 553.
In some embodiments, the ariyoshi that repressor nucleic acid can be the expression of DA1, DA2 and/or EOD1 polypeptide inhibits
Son.
Suitable ariyoshi repressor nucleic acid can be double-stranded RNA (Fire A. et al. Nature, Vol 391, (1998)).
The silencing that dsRNA is mediated is gene specific and commonly referred to as RNA interference (RNAi).RNAi is two step process.It is first
First, dsRNA is cracked in the cell to generate the about 21-23nt length with the end 5' phosphate and the short jag of 3' (about 2nt)
Short interfering rna (siRNA).SiRNA targeting is for destroying specific corresponding mRNA sequence (Zamore P.D.Nature
Structural Biology,8,9,746-750,(2001)。
SiRNA (sometimes referred to as Microrna), which passes through to combine complementation RNA and trigger mRNA, to be eliminated (RNAi) or prevents mRNA
It translates into protein and carrys out down-regulation of gene expression.SiRNA can be obtained by processing compared with long dsrna, and worked as and sent out in nature
Usually there is exogenous origin now.Small-RNA interfering (miRNA) is that the endogenous obtained by processing short hair clip encodes
Small non-coding RNA.SiRNA and miRNA can inhibit the translation of the target sequence for carrying partial complementarity and the mRNA without RNA cracking, and
And degradation carries the mRNA of the sequence of complete complementary.
Therefore, the present invention provides the RNAi sequence based on DA1, DA2 and/or EOD1 nucleic acid sequence for inhibiting DA1, DA2
And/or the purposes of the expression of EOD1 polypeptide.For example, RNAi sequence can correspond to reference DA2, DA1 or EOD1 core listed herein
The segment of nucleotide sequence can be its variant.
SiRNA molecule is usually double-strand, and in order to optimize the effective of the downward of the function of the target gene of RNA mediation
Property, preferably the length of selection siRNA molecule and sequence are to ensure correctly to identify the siRNA (RISC by RISC compound
Compound mediates the identification by the siRNA of mRNA target) and so that the siRNA is as short as being enough to reduce host and answer
It answers.
MiRNA ligand is usually region that is single-stranded and having the partial complementarity for making the ligand be capable of forming hair clip.
MiRNA is from DNA transcription but the untranslated RNA sequence at protein.The DNA sequence dna ratio miRNA long of coding miRNA.This DNA
Sequence includes miRNA sequence and approximate reversed complement.When this DNA sequence dna is transcribed into single strand RNA molecule, miRNA sequence
Column and its base pairing of reverse mutual complement are to form partially double stranded RNA section.The design of microRNA seqeunce in John et al.,
PLoS Biology, 11 (2) discuss on 1862-1879,2004.
Usually, it is intended that the RNA molecule of the effect of simulation siRNA or miRNA has the ribonucleotide between 10 and 40
(or its synthetic analogues), ribonucleotide more preferably between 17 and 30, it is 19 and 25 more preferable between ribose core
Thuja acid and the most preferably ribonucleotide between 21 and 23.In some embodiments of the invention using double-strand siRNA,
The molecule can have the symmetrical 3' jag of such as one or two (ribose) nucleotide, usual dTdT 3' jag
UU.Based on disclosure provided herein, technical staff can easily design suitable siRNA and miRNA sequence, such as using
Resource such as siRNA finder (Ambion).SiRNA and miRNA sequence can be synthetically produced and exogenous add to cause gene
It lowers or is generated using expression system (such as carrier).In a preferred embodiment, siRNA is synthesized syntheticly.
It can be processed in cell compared with long dsrna to generate siRNA (see, for example, Myers (2003) Nature
Biotechnology 21:324-328).Longer dsRNA molecule can have the symmetrical of such as one or two (ribose) nucleotide
3' or 5' jag, or can have flat end.Longer dsRNA molecule can be 25 nucleotide or longer.Preferably, longer
The length of dsRNA molecule is the nucleotide between 25 and 30.It is highly preferred that the length of longer dsRNA molecule is 25 and 27
Between nucleotide.Most preferably, the length of longer dsRNA molecule is 27 nucleotide.Carrier pDECAP can be used to express
Length is the dsRNA (Shinagawa et al., Genes and Dev., 17,1340-5,2003) of 30 nucleotide or more.
Another alternative solution is expression short hairpin RNA molecule (shRNA) in cell.ShRNA is more steady than synthesis siRNA
It is fixed.ShRNA is made of the short inverted repeats by small ring sequence separates.One inverted repeats and gene target are mutual
It mends.In cell, shRNA is processed by siRNA, the siRNA degradation target gene mRNA and inhibition expression by DICER.In
In preferred embodiment, by endogenously generating shRNA (in the cell) from carrier transcription.It can be by rna plymerase iii
Promoter such as people H1 or 7SK promoter or the lower carrier with coding shRNA sequence of rna plymerase ii promoter control transfect cell
Come in the intracellular generation shRNA.Alternatively, can be by synthesizing shRNA (in vitro) exogenously from carrier transcription.Then may be used
ShRNA is directly introduced into the cell.Preferably, shRNA molecule includes the partial sequence of DA1, DA2 and/or EOD1.Example
Such as, the length of shRNA sequence is between 40 and 100 bases, and more preferably length is between 40 and 70 bases.The stem of hair clip
Length preferably between 19 and 30 base-pairs.The stem may include that G-U is matched so that hairpin structure is stablized.
It can be preferably incorporated in the intracorporal nucleic acid sequence of load by transcription and to recombinate prepare siRNA molecule, longer dsRNA
Molecule or miRNA molecule.Preferably, siRNA molecule, longer dsRNA molecule or miRNA molecule include the reference listed herein
The partial sequence of DA2, DA1 or EOD1 nucleotide sequence or its variant.
In other embodiments, repressor nucleic acid can be the Antisense Suppression of the expression of DA1, DA2 and/or EOD1 polypeptide
Son.Come in down-regulation of gene expression using antisense sequences, nucleotide sequence is placed in the control of the promoter in " inverted orientation "
Under, so that transcription generates RNA, the RNA is complementary with the normal mRNA transcribed from " ariyoshi " chain of target gene.See, for example,
Rothstein et al., 1987;Smith et al., (1988) Nature 334,724-726;Zhang et al., (1992) The
Plant Cell 4,1575-1588;English et al., (1996) The Plant Cell 8,179-188.Antisense technology is also
It summarizes in Bourque, (1995), Plant Science 105,125-149 and Flavell (1994) PNAS USA 91,
In 3490-3496.
Antisense Suppression daughter nucleus acid may include from for reference DA2, DA1 or EOD1 nucleotide sequence listed herein or its change
The antisense sequences of at least ten nucleotide of the nucleotide sequence of the segment of body.
It may be preferred that the expression for lowering target sequence sequence with that there are sufficient sequences in the target sequence is same
One property, but the complete complementarity of sequence or similitude are not required.One or more nucleotide in used sequence
It can be different from target gene.Therefore, the sequence used in the downward of gene expression according to the present invention can be selected from obtainable
The variant of those wild-type sequence (such as gene) or this sequence.
The sequence need not include open reading frame or it is specified will be interpretable RNA.It is corresponded to it may be preferred that existing
Enough homologys of antisense and ariyoshi RNA molecule are to hybridize.There may be the downwards of gene expression, even if in used sequence
In the case where there is about 5%, 10%, 15% or 20% or more mispairing between target gene.Effectively, homology should be enough to use
In the downward that gene expression occurs.
Repressor RNA molecule may include the sense or antisense chain of the nucleic acid sequence of encoding D A2, DA1 and/or EOD1 polypeptide
10-40 nucleotide.
Repressor nucleic acid can be operably coupled to allogeneic promoter, such as tissue specificity or inducible promoter.
For example, integument and seed specific promoters can be used for two or more in specifically lower levelling development ovule and seed
DA1, DA2 and/or EOD1 nucleic acid are to increase final seed size.
In some preferred embodiments, DA2 repressor nucleic acid can with encoding dominant negative feminine gender DA1 polypeptide and optionally
It is expressed in the plant cell of the nucleic acid of ground EOD1 repressor nucleic acid.
The nucleic acid for encoding repressor nucleic acid and/or dominant negative DA1 polypeptide may include in one or more carriers.
The nucleic acid for encoding repressor nucleic acid as described herein and/or dominant negative DA1 polypeptide can operationally connect
It is connected to heterologous regulatory sequence, such as promoter, such as composing type as described above, induction type, tissue specificity or development-specific
Promoter.
The nucleic acid for encoding repressor nucleic acid as described herein and/or dominant negative DA1 polypeptide may include in nucleic acid structure
It builds on body or carrier.The construct or carrier are preferably adapted for conversion table into plant cell and/or in plant cell
It reaches.Carrier is especially in double-strand or single-stranded linear or annular form any plasmid, clay, bacteriophage or Agrobacterium binary
Carrier, it is self can shifting or moveable that the carrier can be or can not be, and the carrier can be by being integrated into
There is (for example, plasmid that autonomous duplication has replication orgin) to convert protokaryon or eukaryon in cellular genome or chromosome other places
Host, specifically plant host.
It specifically include shuttle vector, shuttle vector means natively or passes through design can be in two different organisms
The DNA medium of middle duplication, the DNA medium can be selected from actinomyces and relative species, (such as the high plant of bacterium and eukaryon
Object, mammal, yeast or fungi) cell.
Construct or carrier as described above including nucleic acid need not be including promoter or other regulating and controlling sequences, especially such as
Carrier described in fruit, which is not used in, to be introduced into nucleic acid in cell to be used to recombinate into genome.
Construct and carrier may also include by assign may be selected phenotype (such as to the resistance of antibiotic) gene form can
Select genetic marker, the antibiotic such as kanamycins, hygromycin, glufosinate (phosphinotricin), chlorsulfuron, first
Aminopterin, gentamicin, spectinomycin, imidazolone type, glyphosate and d- amino acid.
Those skilled in the art can for example in microorganism or plant cell carrier construction and designed for recombination base
Because of the scheme of expression.It may be selected or construct the suitable carrier for containing regulating and controlling sequence appropriate, the regulating and controlling sequence includes promoter
Sequence terminates sub-piece, polyadenylation sequence, enhancer sequence, marker gene and other sequences appropriate.For into one
Details is walked, see, for example, Molecular Cloning:a Laboratory Manual: the 3 edition, Sambrook et al.,
2001, Cold Spring Harbor Laboratory Press and Protocols in Molecular Biology, second
Version, Ausubel et al. edit John Wiley&Sons, 1992.Previously used has extensively successfully specific journey on plant
Sequence and carrier are by Bevan, Nucl.Acids Res. (1984) 12,8711-8721) and Guerineau and Mullineaux,
(1993)Plant transformation and expression vectors.In:Plant Molecular Biology
Labfax (Croy RRD is edited) Oxford, BIOS Scientific Publishers, the 121-148 pages description.
When selected gene construct is introduced cell, it is necessary to consider well-known to those having ordinary skill in the art certain examine
Consider.The nucleic acid being inserted into should include that will assemble in the construct of the Effective Regulation element of driving transcription.There must be available
Method construct being transported in cell.Once in cell membrane, endogenous will occur or will not be integrated into for construct
In chromosomal material.Finally, target cell type is preferably so that cell can be reproduced into full plants.
It is desirable for the construct of the expression of the nucleic acid of enhancing coding repressor nucleic acid or dominant negative DA1 polypeptide and turns
Change method.The single copy of gene, which is integrated into the genome of plant cell, may be beneficial to make gene silencing effect minimum
Change.Equally, control integration complexity can be in this regard it is beneficial.In this regard it is particularly interesting that using according to example
Plant cell is converted such as the minimum gene expression construct of european patent number EP1407000B1, the patent is for this purpose
It is hereby incorporated herein by.
Technology well-known to those having ordinary skill in the art can be used for for nucleic acid construct and carrier being introduced in plant cell with
Generate the genetically modified plants with characteristic as described herein.
Agrobacterium conversion is that a kind of method of conversion plant species is widely used in by those skilled in the art.It generates
Stable fertile genetically modified plants be now it is conventional in the art (see, for example, Toriyama, et al. (1988) Bio/
Technology 6,1072-1074;Zhang, et al. (1988) Plant Cell Rep.7,379-384;Zhang, et al.
(1988)Theor Appl Genet 76,835-840;Shimamoto, et al. (1989) Nature 338,274-276;
Datta, et al. (1990) Bio/Technology 8,736-740;Christou, et al. (1991) Bio/Technology 9,
957-962;Peng, et al. (1991) International Rice Research Institute, Manila,
Philippines 563-574;Cao, et al. (1992) Plant Cell Rep.11,585-591;Li, et al. (1993)
Plant Cell Rep.12,250-255;Rathore, et al. (1993) Plant Molecular Biology 21,871-
884;Fromm, et al. (1990) Bio/Technology 8,833-839;Gordon-Kamm, et al. (1990) Plant Cell
2,603-618;D'Halluin, et al. (1992) Plant Cell 4,1495-1505;Walters, et al. (1992) Plant
Molecular Biology 18,189-200;Koziel, et al. (1993) Biotechnology 11,194-200;Vasil,
I.K.(1994)Plant Molecular Biology 25,925-937;Weeks, et al. (1993) Plant Physiology
102,1077-1084;Somers, et al. (1992) Bio/Technology 10,1589-1594;WO92/14828;
Nilsson, O. et al. (1992) Transgenic Research 1,209-220).
Other methods, such as particle or partickle bombardment (US 5100792, EP-A-444882, EP-A-434616), electroporation
(EP 290395, WO 8706614), microinjection (WO 92/09696, WO 94/00583, EP 331083, EP 175966,
Green et al. (1987) Plant Tissue and Cell Culture, Academic Press), direct DNA absorb (DE
4005152, WO 9012096, US 4684611), liposome-mediated DNA intake (such as Freeman et al. Plant Cell
Physiol.29:1353 (1984)) or vortex methods (such as Kindle, PNAS U.S.A.87:1228 (1990d)) in soil
It in the case that Bacillus conversion is inefficient or invalid, such as in some gymnosperm species may be preferred.It is planted for converting
The physical method of object cell is summarized in Oard, 1991, Biotech.Adv.9:1-11.
Alternatively, the combination of different technologies can be used for enhancing the efficiency of conversion process, such as coated with Agrobacterium micro-
Partickle bombardment (EP-A-486234) or microparticle bombardment then co-culture (EP-A- with Agrobacterium to induce wound
486233)。
After conversion, can be for example from individual cells, callus or leaf dish aftergrowth, such as standard in the art
's.Substantially any plant can all regenerate completely from the cell, tissue and organ of plant.Available technology summary in Vasil et al.,
Cell Culture and Somatic Cell Genetics of Plants, I, II and III volumes, Laboratory
Procedures and Their Applications, Academic Press, 1984 and Weissbach and
Weissbach, Methods for Plant Molecular Biology, Academic Press, in 1989.
The specific choice of transformation technology will be converted the efficiency of certain plants species by it and practice the warp of people of the invention
It tests and determines with preference with specific selection method.It will be clear to the skilled person that by the transformation system of nucleic acid into plant cells
The specific choice of system is not limitation required in this invention or of the invention, nor the selection of the technology for plant regeneration.
After conversion, can identify and/or select to express with reduceds DA2 expression and reduced DA1 and/or EOD1 or
Active plant cell.It can be from the plant cell aftergrowth.
Plant as described above that also lack both DA1, EOD1 or DA1 and EOD1 with reduced DA2 activity or expression
Object can sexual or vegetative propagation or growth to generate filial generation or offspring.Can sexual or vegetative propagation or growth from one or more thin
The filial generation of the regenerated plant of born of the same parents or offspring.Plant or its filial generation or offspring can hybridize with other plant or with itself.
DA1, DA2 and/or EOD1 amino acid or nucleic acid sequence can be used as molecular marker come grow it is sexual or asexual
The table of one or more DA1, DA2 and/or EOD1 polypeptides out as listed above in plant is measured before, during or after breeding
It reaches or active.A kind of method can include:
The group of plant is provided,
The amount of the expression of DA1, DA2 and/or EOD1 polypeptide in one of described group or various plants is measured, and
Identifying in the group has reduced DA1, DA2 and/or EOD1 polypeptide relative to other members of the group
One or more plants of expression.
The plant population can be generated as described above.
In some embodiments, a kind of method can include:
Make the first and second plant hybridizations to generate the group of progeny plants;
The expression of one of described progeny plants in the group or a variety of DA1, DA2 and EOD1 polypeptides is measured, with
And
Identify the expression of DA1, DA2 and/or EOD1 polypeptide described in the group progeny plants reduced relative to control.
One or both of first plant and second plant can be generated as described above.
The expression of DA2 and DA1 and/or EOD1 polypeptide is reduced relative to control (for example, other members of the group)
Progeny plants can show relative to the increased seed of the control and/or organ size and can have higher plant products.
In some embodiments, DA1 and EOD1 amino acid or nucleic acid sequence can be used as molecular marker to measure in plant
One or more DA1 and/or EOD1 polypeptides expression or activity, so as to identify lack DA1 and/or EOD1 plant or plant
Cell, the expression of DA2 polypeptide or activity can be lowered as described above in the plant or plant cell.A kind of method can wrap
It includes:
The group of plant is provided,
The amount of the expression of the DA1 and/or EOD1 polypeptide in one of described group or various plants is measured, and
Identifying in the group has reduced DA1 and/or EOD1 polypeptide expression relative to other members of the group
One or more plants.
DA2 expression or activity can be reduced in the plant identified using method as described above.
Can by DA1 in the following one or more cells for measuring the plant come differential plant or progeny plants i),
The amount of DA2 and/or EOD1 polypeptide, ii) the measurement plant one or more cells in DA1, DA2 and/or EOD1 mRNA
Amount or iii) nucleic acid of DA1, DA2 and/or EOD1 polypeptide in the one or more cells for encoding the plant is surveyed
Sequence and the presence for identifying one or more mutation.
The plant identified further can be bred or be hybridized, for example, with have reduced DA1, DA2 and/or EOD1 table
The other plant reached hybridizes or from hybridization to generate self-mating system.DA1, DA2 and/or EOD1 in the group of progeny plants can be measured
The expression of polypeptide or activity and identification have reduced DA1, DA2 and/or EOD1 expression or active one or more offsprings
Plant.
In some embodiments, the amount of the expression of DA1, DA2 and/or EOD1 can be measured under protein level.A kind of side
Method can include:
The group of plant is provided,
The amount of DA1, DA2 and/or EOD1 polypeptide in one or more plants of the group is measured, and described in identification
There are in group relative to other members of the group one or more plants of reduced DA1, DA2 and/or EOD1 polypeptide amount
Object.
Advantageously, immunological technique such as Western blotting can be used, using combination DA1, DA2 or EOD1 polypeptide and display and plant
The less combination of other antigens in object or the antibody without combination.For example, DA1, DA2 and/or EOD1 polypeptide in plant cell
Amount can measure in the following manner: make include the plant cell sample be directed to DA1, DA2 or EOD1 polypeptide
Antibody or other specific binding members are in contact, and measure the combination of DA1, DA2 or EOD1 polypeptide and the sample.
The amount for DA1, DA2 or EOD1 polypeptide that the amount instruction of the combination of specific binding members is expressed in cell.
It can be in one or more cells of plant, preferably in aerial part or tissue from plant, in tender shoots
Vascular system and nascent and secondary meristem cell in measure the amount of DA1, DA2 and/or EOD1 polypeptide.
In other embodiments, the expression of DA1, DA2 or EOD1 polypeptide can be measured under nucleic acid level.For example, can measure
The amount of the nucleic acid of encoding D A1, DA2 or EOD1 polypeptide.Generating has a kind of method of the plant of increased Correlated Yield Characters can
Include:
The group of plant is provided,
Measure in the cell of one or more plants of the group nucleic acid of encoding D A1, DA2 or EOD1 polypeptide for example
The level or amount of mRNA, and
Identifying in the group has reduced DA1, DA2 or EOD1 code nucleic acid relative to other members of the group
Amount one or more plants.
The level or amount of code nucleic acid in plant cell can for example pass through the coding core of the transcription in the detection cell
The amount of acid measures.Standard technique such as RNA trace or RT-PCR can be used to carry out for this.
Alternatively, can the expression of determination influences DA1, DA2 or EOD1 polypeptide or the presence of active sequence variations.Generation has
Another method of the plant of increased growth and/or biomass can include:
The group of plant is provided,
Measure the nucleic acid of encoding D A1, DA2 and/or EOD1 polypeptide in the cell in one or more plants of the group
One of or a variety of sequence variations (for example, polymorphism, mutation or supermethylation region) presence,
Wherein one or more sequence variations reduce DA1, DA2 and/or EOD1 polypeptide of the coding expression or
Activity, and
Identify has the expression for reducing DA1, DA2 and/or EOD1 relative to other members of the group in the group
Or one or more plants of active one or more sequence variations.
DA1, DA2 and/or EOD1 polypeptide and code nucleic acid are being described in more detail above.
The presence of one or more sequence variations can be by detecting variant nucleic in one or more plant cells in nucleic acid
The presence of sequence is measured by detecting by the presence of the variant polypeptide of the nucleic acid sequence encoding.Preferred variable nucleic acid sequence
Different detection technique includes ARMSTMAllele specific amplification, OLA, ALEXTM, COPS, Taqman, molecular beacon, RFLP with
And the PCR and FRET technology based on restriction site.
For measure the nucleic acid of encoding D A1, DA2 or EOD1 polypeptide in plant cell amount or encoding D A1, DA2 or
Present or absent many suitable methods of sequence variations in the nucleic acid of EOD1 polypeptide are obtainable (ginsengs in this field
See for example (see, for example, Molecular Cloning:a Laboratory Manual: the 3 edition, Sambrook&Russell
(2001)Cold Spring Harbor Laboratory Press NY;Current Protocols in Molecular
Biology, Ausubel et al. edit John Wiley&Sons (1992);DNA Cloning,The Practical
Approach Series (1995), series editor D.Rickwood and B.D.Hames, IRL Press, Oxford, UK and
PCR Protocols:A Guide to Methods and Applications (Innis, et al. 1990.Academic
Press,San Diego,Calif.)).Many current methods for detection sequence variation by Nollau et al.,
Clin.Chem.43,1114-1120,1997;And in standard textbook such as " Laboratory Protocols for
Mutation Detection ", U.Landegren are edited, Oxford University Press, and 1996 and " PCR ", second edition
Newton&Graham, BIOS Scientific Publishers Limited is summarized in 1997.
Preferred polypeptide sequence mutation includes immunoassays, immunoassays be it is well-known to those having ordinary skill in the art,
Such as A Practical Guide to ELISA, D M Kemeny, Pergamon Press 1991;Principles and
Practice of Immunoassay, second edition, C P Price&D J Newman, 1997, by America & Canada
The Stockton Press and Macmillan Reference of Britain is published.
In some embodiments, nucleic acid or its amplification region can be sequenced with identify or measure polymorphism therein or
The presence of mutation.Can by by the known array of sequence obtained and DA1, DA2 or EOD1 (for example, as in sequence database
It is listed) it is compared to identify polymorphism or mutation.Alternatively, can be by sequence obtained and the corresponding core from control cell
The sequence of acid is compared.Specifically, the one or more polymorphisms for causing the reduction of function but not exclusively eliminating can be measured
Or the presence of mutation.Can be used in series of standards technology any is sequenced.The sequencing of amplified production can be related to for example
And with isopropanol precipitating, resuspension and using TaqFS+Dye terminator sequencing kit (such as from GE Healthcare UK
Ltd UK) sequencing.Extension products can carry out electrophoresis in 377 DNA sequencer of ABI and use Sequence Navigator soft
Part analyzes data.
It can be for right relative to increased or enhancing Correlated Yield Characters (such as increased seed or organ size) are compareed
It is identified as being tested with the progeny plants that reduced DA1, DA2 and/or EOD1 are expressed.
The progeny plants identified further can be bred or be hybridized, such as (be returned with first or second plant hybridization
Hand over) or hybridize certainly to generate self-mating system.
Can relative to comparison needle to seed size, organ size and/or plant products come to the progeny plants identified into
Row test.
The plant generated as described herein can lack DA2 expression or activity and can also lack DA1 expression or activity, EOD1
Expression or activity or both DA1 and EOD1 expression or activity.
Inhibition daughter nucleus can be encoded by the mutation of one or more nucleotide in plant code sequence and/or by expression
The heterologous nucleic acids of acid reduce or eliminate the expression or activity of DA2, DA1 and EOD1 in plant.In some preferred embodiments
In, the activity of the DA1 in plant can be reduced or eliminated by the heterologous nucleic acids of the DA1 polypeptide of expression encoding dominant negative feminine gender.
Therefore plant may include heterologous nucleic acids, the heterologous nucleic acids encode repressor nucleic acid such as siRNA or shRNA, described
Repressor nucleic acid reduces the expression of one or more of DA1, DA2 and EOD1 or the DA1 polypeptide of encoding dominant negative feminine gender.
It can be in plant as described herein using mutation, any combination of repressor nucleic acid.For example, plant may include i)
Heterologous nucleic acids and the fgs encoder for reducing the repressor nucleic acid of mutation, the coding reduction EOD1 expression of DA2 activity or expression are aobvious
Property negative DA1 polypeptide nucleic acid heterologous nucleic acids;Ii) coding reduces the heterologous nucleic acids of the repressor nucleic acid of DA2 expression, reduces
The heterologous nucleic acids of the nucleic acid of the mutation and dominant negative DA1 polypeptide of fgs encoder of EOD1 expression;Iii) coding reduces EOD1
With the heterologous nucleic acids of the nucleic acid of the heterologous nucleic acids and dominant negative DA1 polypeptide of fgs encoder of the repressor nucleic acid of DA2 expression;Or
Iv the heterologous nucleic acids of the nucleic acid of the mutation and dominant negative DA1 polypeptide of fgs encoder of EOD1 and DA2 activity or expression) are reduced.
In other embodiments, plant may include i) reducing DA2 activity or the mutation expressed, coding to reduce DA1 and express
The heterologous nucleic acids of repressor nucleic acid;Ii) coding reduces the heterologous nucleic acids of the repressor nucleic acid of DA2 expression, reduces the prominent of DA1 expression
Become;Iii) coding reduces the heterologous nucleic acids of the repressor nucleic acid of DA1 and DA2 expression;Iv) reduce DA1 and DA2 activity or expression
Mutation;Or v) reduce the heterologous nucleic acids and volume of the repressor nucleic acid of mutation or the coding reduction DA2 expression of DA2 activity or expression
The heterologous nucleic acids of the nucleic acid of the DA1 polypeptide of code encoding dominant negative feminine gender.
The DA1 polypeptide of encoding dominant negative feminine gender and/or the heterologous nucleic acids of repressor nucleic acid can be in identical or different expression
On carrier and it can be incorporated in plant cell by routine techniques.
The example of the suitable plant used for any aspect according to invention as described herein includes monocotyledon
With dicotyledonous high-grade plant, such as agricultural plant or crop, it is such as selected from the plant for the group being made of the following terms: Asian puccoon
(Lithospermum erythrorhizon), Taxus, tobacco, cucurbit, carrot, Vegetables in Brassica, melon, capsicum, Portugal
Grape tree, lettuce, strawberry, Brassica genus oily seed, beet, wheat, barley, corn, rice, soybean, pea, jowar, sunflower,
Tomato, potato, pepper, chrysanthemum, carnation, linseed, hemp and rye.The plant generated as described above can sexual or nothing
Sexual reproduction or growth are to generate filial generation or offspring.Can sexual or vegetative propagation or growth from the plants of one or more cytothesises
Filial generation or offspring.Plant or its filial generation or offspring can hybridize with other plant or with itself.
Another aspect of the present invention provides genetically modified plants, and the genetically modified plants have into the cell in one or more
DA2 polypeptide expression or activity reduce or elimination, wherein the plant lacks the expression of both DA1, EOD1 or DA1 and EOD1
Or activity.
The plant may include exogenous nucleic acid, the exogenous nucleic acid reduce or eliminate one of DA2, DA1 and EOD1 or
The expression or activity of more persons.In some embodiments, genetically modified plants can express the active dominant negative DA1 for reducing DA1
Polypeptide.
In some embodiments, the plant can have reduction or elimination DA1, DA2 and EOD1 to express or can have
DA2 and EOD1 reduce or elimination are expressed and can be expressed dominant negative DA1.
Except through the plant that method described herein generates, the present invention covers the plant, seed, selfing or hybridization
Generation or offspring any clone and these any one of any part or brood body can be used for such as cutting and seed
Breeding or breeding, it is sexual or asexual.Present invention also contemplates that plant, the plant is sexual or vegetative propagation the son of this plant
Generation, clone or offspring or the plant, filial generation, clone or offspring any part or brood body.
Suitable plant can be generated by the above method.
The plant can relative to control wild-type plant (expression of i.e. wherein DA2 and optionally DA1 and/or EOD1 or
The identical plant that activity not yet reduces) there is increased yield.For example, per unit area seed (such as grain) or other plant
The quality of product can increase relative to check plant.
For example, one of plant or a variety of Correlated Yield Characters can be improved.Correlated Yield Characters may include service life, organ
Size and seed size.
Correlated Yield Characters can improve relative to check plant, increase or enhance the Correlated Yield Characters in plant, in institute
State the expression of the nucleic acid of encoding D A2 polypeptide in check plant do not eliminate or reduce again (i.e. wherein DA2 and optionally DA1 and/or
The identical plant that the expression of EOD1 not yet reduces or eliminates).
Plant according to the present invention can be the plant of the not pure breeding in one or more characteristics.Botanical variety can be excluded,
Botanical variety is registered in particular according to planting person's right.
DA1 shown herein in vivo with DA2 Physical interaction.Destroy or interfere the compound of the interaction can
Suitable for increasing seed or organ size and improving plant products.
Identify the method for increasing the compound of plant products can include:
Effect of the measurement test compound to the combination of DA2 polypeptide and DA1 polypeptide,
In conjunction with the instruction compound that reduces or eliminates be applicable to increase plant products.
DA1 and DA2 polypeptide is being described in more detail above.
It is that DA1 and DA2 polypeptide can be separation or can recombinate in plant cell or endogenously express.
The compound for reducing or eliminating DA1/DA2 combination is applicable to processing plant to increase yield.
The specific of each that "and/or" should be considered as in two kinds of specific characteristics or component when using herein discloses
Or without another one.For example, " A and/or B " should be considered as the specific disclosure of each of (i) A, (ii) B and (iii) A and B,
It is individually listed just as each herein.
Unless context dictates otherwise, otherwise the description and definition of feature listed above are not limited to any tool of the invention
In terms of body or embodiment and it is equally applicable to described all aspect and embodiment.
Other aspects of the present invention and embodiment provide wherein term " includes " by term " by ... form " substitute with
The above that the aspect and embodiment and wherein term " includes " are substituted by term " substantially by ... form "
Aspect and embodiment.
The All Files referred in the present specification are incorporated herein in its entirety by reference for all purposes.
The content of all data base entries referred in the present specification for all purposes it is whole by reference simultaneously
Enter herein.This includes the version in the submission date of the application current any sequence.
Experiment
1. method
1.1 vegetable materials and growth conditions
Arabidopsis Columbia ecotype (Col-0) is used wild type system.All mutant are in Col-0 background
Under.Da2-1 (SALK_150003) is obtained from arabidopsis inventory center NASC and ABRC preservation.It is true by PCR and sequencing
Recognize T-DNA insertion.By seed 100% isopropanol surface sterilizing 1 minute and with 10% (v/v) household bleach surface sterilizing
10 minutes, at least three times with sterile water washing, stratification 3 days in the dark at 4 DEG C, on GM culture medium with 0.9% agar and
The dispersion of 1% glucose, and then grown at 22 DEG C.By plant under long-day conditions (16 small time/8 hour dark)
It is grown at 22 DEG C.
1.2 constructs and conversion
PDA2:DA2 construct is prepared by using the Gateway system of based on PCR.Using primer DA2proGW-F and
DA2proGW-R expands the 1960bp promoter sequence of DA2.Then PCR product is cloned into pCR8/GW/TOPO TA clone
In carrier (Invitrogen).Amplification DA2 CDS and then AscI that PCR product is cloned into Gateway carrier pMDC110
With the site KpnI to obtain DA2CDS-pMDC110 plasmid.Then it is reacted by LR and DA2 promoter is subcloned to DA2CDS-
PMDC110 is to generate pDA2:DA2 construct.Plasmid pDA2:DA2 da2-1 is introduced to using Agrobacterium tumefaciens GV3101 to dash forward
Transformant is selected in variant plant and on the culture medium containing hygromycin (30 μ g/ml).
35S:DA2 construct is prepared using the Gateway system of based on PCR.PCR product is subcloned using TOPO enzyme
Into pCR8/GW/TOPO TA cloning vector (Invitrogen).Then DA2 gene is subcloned to containing 35S promoter
In Gateway binary vector pMDC32 (Curtis and Grossniklaus, 2003).Using Agrobacterium tumefaciens GV3101 by matter
Grain 35S:DA2 is introduced in Col-0 plant and selects transformant on the culture medium containing hygromycin (30 μ g/ml).
It expands the 1960bp promoter sequence of DA2 and PCR product is cloned into pGEM-T carrier using T4DNA ligase
(Promaga) it in and is sequenced.Then DA2 promoter is inserted into the site SacI and NcoI of binary vector pGreen-GUS
(Curtis and Grossniklaus, 2003) converts plasmid pDA2:GUS to generate.Using Agrobacterium tumefaciens GV3101 by matter
Grain pDA2:GUS is introduced in Col-0 plant and selects transformant on the culture medium of (50 μ g/ml) containing kanamycin.Make
35S:GW2 construct is prepared with the Gateway system of based on PCR.PCR product is subcloned to pCR8/GW/ using TOPO enzyme
In TOPO TA cloning vector (Invitrogen).Then GW2 gene is subcloned to the Gateway binary containing 35S promoter
In carrier pMDC32 (Curtis and Grossniklaus, 2003).Plasmid 35S:GW2 is drawn using Agrobacterium tumefaciens GV3101
Enter into Col-0 plant and selects transformant on the culture medium containing hygromycin (30 μ g/ml).
1.3 morphology and cell analysis
It is weighed in 500 batch by using electronic analytical balance (METTLER MOLEDO AL104CHINA) maturation
Dry seeds measure Average seed weights.The weight of five sample batch is measured for each seed seed lot.Use Lycra CCD
(DFC420) it is taken pictures at Leica microscope (LEICA S8APO) to seed and is measured by using Image J software
Seed size.The area measurement in petal (stage 14), leaf and cotyledon is carried out to generate digital picture by scanning organ, and
Then by using Image J software reference area, length and width.It is big from DIC image measurement leaf, petal and embryo cell
It is small.The biomass accumulation in flower (stage 14) is measured by weighing organ.
1.4 GUS dyeing
By sample (pDA2:GUS) in 1mM X-gluc, 100mM Na3PO4 buffer, respective 3mM K3Fe (CN) 6/
K4Fe (CN) 6,10mM EDTA and 0.1%Nodidet-P40 solution in dye, and be incubated at room temperature 6 hours.In
After GUS dyeing, chlorophyll is removed using 70% ethyl alcohol.
1.5 RNA separation, RT-PCR and quantitative Real time RT-PCR analysis
Using RNeasy Plant Mini kit (TIANGEN, China) from arabidopsis root, stem, leaf, seedling and flower
Sequence extracts total serum IgE.As described (Li et al. people, 2006) carries out reverse transcription (RT)-PCR.Use primer ACTIN2-F and ACTIN2-
CDNA sample is based on actin transcript amount and is standardized by R.It is used with lightcycler 480engine (Roche)
Lightcycler 480SYBR Green Master (Roche) carries out quantitative Real time RT-PCR analysis.ACTIN7 mRNA is used as
Internal contrast, and the relative quantity of mRNA is calculated using threshold cycle method is compared.
The measurement of 1.6 E3 ubiquitin ligase activities
The coded sequence of DA2 is cloned into the site BamH I and PstI of pMAL-C2 carrier to generate construct MBP-
DA2.By the DA2 (DA2C59S for generating mutation according to the instruction manual of more site directed mutation kits (Stratagene)
And DA2N91L).
From the MBP-DA2's for expressing MBP-DA2 and mutation with the e. coli bl21 preparation of 0.4mM IPTG induction 2 hours
Bacterial Lysates.By bacterium TGH dissolve buffer (50mM HEPES [pH 7.5], 150mM NaCl, 1.5mM MgCl2,
1mM EGTA, 1%Triton X-100,10% glycerol and protease inhibitor cocktail [Roche]) in dissolve and carry out
Ultrasonic treatment.By lysate by centrifugal clarification and with amylose resin (New England Biolabs) together at 4 DEG C
It is lower to be incubated for 30 minutes.Bead is washed by column buffer (20mM Tris pH7.4,200mM NaCl, 1mM EDTA), and
It is balanced by reaction buffer (50mM Tris pH7.4,20mM DTT, 5mM MgCl2,2mM ATP).By 110ng E1
(Boston Biochem), 170ng E2 (Boston Biochem), 1 μ g His- ubiquitin (Sigma-Aldrich) and 2 μ g
DA2-MBP or the DA2-MBP fusion protein of mutation are incubated for 2 hours at 30 DEG C in 20 μ l reaction buffers.
By being printed with the antibody for His (Abmart) and for the antibody mediated immunity of MBP (New England Biolabs)
Mark detects poly-ubiquitin protein matter.
1.7 external protein-protein interactions
The coded sequence of DA1, da1-1 and DA1 derivative containing specific protein domains is cloned into pGEX-
To generate GST-DA1, GST-DA1R358K, GST-DA1-UIM and GST- in BamH I and the Not I site of 4T-1 carrier
DA1-LIM+C construct, and be cloned into the site EcoRI and XhoI of pGEX-4T-1 carrier with generate GST-DA1-LIM and
GST-DA1-C construct.
For test protein-protein interaction, the bacterium that will contain about the MBP-DA2 fusion protein of 15 μ g is molten
It solves product and contains GST-DA1, GST-DA1R358K, GST-DA1-UIM, GST-DA1-LIM, GST-DA1- of about 30 μ g
The lysate of LIM+C or GST-DA1-C fusion protein merges.By 20 μ l amylose resin (New England
Biolabs it) is added in each combined solution, continues to shake 1 hour at 4 DEG C.Bead is washed repeatedly with TGH buffer,
And isolated protein is separated on 10%SDS- polyacrylamide gel and respectively with anti-GST antibody (Abmart) and
Anti- MBP antibody (Abmart) is detected by western blot analysis.
1.8 co-immunoprecipitation
The coded sequence of DA1 and DA1-C is cloned into the site KpnI and BamHI of pCAMBIA1300-221-Myc carrier
In with generate convert plasmid 35S::Myc-DA1 and 35S::Myc-DA1-C.PCR product is subcloned to pCR8/ using TOPO enzyme
In GW/TOPO TA cloning vector (Invitrogen).Then DA2 gene is subcloned to containing 35S promoter and GFP gene
Gateway binary vector pMDC43 in (Curtis and Grossniklaus, 2003).Using TOPO enzyme by sub- gram of PCR product
It is grand into pCR8/GW/TOPO TA cloning vector (Invitrogen).Then PEX10 gene is subcloned to containing 35S and is started
In the Gateway binary vector pH7FWG2 of son and GFP gene.
Ben's Tobacco Leaf is possessed to the Agrobacterium tumefaciens of 35S:Myc-DA1 and 35S:GFP-DA2 plasmid by injection
GV3101 cell is converted, (Voinnet et al., 2003) as described previously.With Extraction buffer (50mM Tris/HCl
(pH 7.5), 150mM NaCl, 20% glycerol, 2%Triton X-100,1mM EDTA, the mixing of 1 × adequate proteins enzyme inhibitor
Object (Roche) and MG13220ug/ml) extract gross protein and to be incubated for 1 at 4 DEG C with GFP-Trap-A (Chromotek) small
When.By bead washing buffer (50mM Tris/HCl (pH 7.5), 150mM NaCl, 0.1%Triton X-100 and 1
× adequate proteins Protease Inhibitor Cocktail (Roche)) washing 3 times.By immunoprecipitate in 10%SDS- polyacrylamide gel
It is middle to separate and examined respectively with anti-GFP antibody (Beyotime) and anti-Myc antibody (Abmart) by western blot analysis
It surveys.
1.9 accession number
The arabidopsis gene group project gene seat identifier for the arabidopsis gene being mentioned above is as follows: At1g19270 (NP_
173361.1GI:15221983)(DA1)、At4g36860(NP_195404.6GI:240256211)(DAR1)、At1g78420
(NP_001185425.1GI:334183988) (DA2), At1g17145 (NP_564016.1GI:18394446) (DA2L) and
At3g63530(NP_001030922.1GI:79316205)(EOD1/BB)。
2. result
2.1 da2-1 mutant generate big seed
In order to further appreciate that ubiquitin mediate seed size control mechanism, we have collected several microarrays study
In the T-DNA obtained that discloses of the ubiquitin ligase genes of some predictions that is expressed in arabidopsis ovule and/or seed insert
Enter and is and its seed growth phenotype is studied.From this screening, we be authenticated with the seed size changed
Several T-DNA insertion mutation bodies.Discovery sequence with reference to big seed size mutant is specified by one in these mutant
For da2-1 (DA means " big " in Chinese).By da2-1 generate seed it is bigger than wild type seeds and heavier (Figure 1A, 3C and
3D).In da2-1 the seed production of the number seeds of every silique and every plant those of be slightly higher than in wild type (Figure 1B and
1C).In contrast, compared to the total number of every plant seed in wild type, the total number of every plant seed is not shown in da2-1
It writes and increases (Fig. 1 D).Da2-1 plant is higher than WT lines (Fig. 1 E) in the maturity period.In addition, compared to WT lines, da2-
1 mutant plants form biggish flower and leaf and increased biomass (Fig. 2;Figure 15).Da2-1 mutant petal and leaf it is big
Small increase is not as caused by biggish cell (Figure 15), thus instruction be petal and leaf cell number it is higher.
2.2 DA2 and DA1 act synergistically to control seed size, but controls seed size independently of EOD1
Da2-1 mutant shows weak but similar with da1-1 seed size phenotype (Li et al. people, 2008), refers to provide
Show that DA1 and DA2 can be worked with common pathway.In order to test the genetic interaction between DA1 and DA2, we are made
Da1-1 da2-1 double-mutant and determine its seed size.Although da2-1 mutant have it is more slightly greater than wild type and
Heavier seed (Figure 1A, 3C and 3D), but da2-1 mutation collaboration enhancing da1-1 Seed size and weight phenotype (Fig. 3 A and
3C), genetic interaction is cooperateed between DA1 and DA2 in terms of seed size to disclose.The variation of seed size is reflected in
In the size of plumule and gained seedling (Fig. 3 B).Further measure the cotyledon area of 10 day age seedling.Also it observes and passes through
The collaboration that da2-1 is mutated the cotyledon size of da1-1 enhances (Fig. 3 B and 4).The mutant protein tool encoded by da1-1 allele
There is the cathode active (Li et al. people, 2008) for DA1 and DA1 GAP-associated protein GAP (DAR1) (most closely related family member).
Double da1-ko1 dar1-1T-DNA insertion mutation body surfaces reveal da1-1 phenotype, and da1-ko1 and dar1-1 is mono- prominent
Variant does not show apparent seed size phenotype (Li et al. people, 2008).Because da1-1 and da2-1 synergistic effect is to increase seed
Expected da1-ko1 can be cooperateed with the phenotype of enhancing da2-1 by size.In order to test this point, da1-ko1 da2- has been made in we
1 double-mutant.As shown in fig.3d, the Seed size and weight phenotype of da2-1 is mutated collaboration enhancing also by da1-ko1.Into
The one step surveying cotyledon area of 10 day age seedling.Da1-ko1 mutation collaboration enhances the cotyledon size phenotype (right side Fig. 4 of da2-1
On).Similarly, it was further observed that the petal size (Figure 16 D) of collaboration enhancing da2-1 is mutated by da1-ko1.These results are into one
Step proves the synergistic effect destroyed while both DA1 and DA2.
Further measure the size of embryo cell and petal epidermal cell.Compared to the cell measured in its parental department
The cell size of size, da1-1 da2-1 and da1-ko1 da2-1 double-mutant does not increase the (lower-left Fig. 4;Figure 16 E), to mention
Proliferation process is limited for instruction DA1 and DA2 synergistic effect.
Da1-1 da2-1 double-mutant has the seed (Fig. 3 C, 3D and 4) bigger than da1-ko1 da2-1 double-mutant,
This has phenotype more stronger than da1-ko1 consistent (Li et al. people, 2008) with the da1-1 allele that we are previously reported.da1-1
The size of seed is similar to the size of da1-ko1 dar1-1 double-mutant seed, because da1-1 allele, which has, is directed to DA1
With the cathode active (bottom right Fig. 4) (Li et al. people, 2008) of DAR1.Therefore, by the big of expected da1-1 da2-1 double-mutant seed
The small size that may look like da1-ko1 dar1-1 da2-1 Trimutant seed.Then da1-ko1 has been made in we
Dar1-1 da2-1 Trimutant and its seed size is studied.As shown in Figure 4, da1-ko1 dar1-1
The comparable size of da2-1 Trimutant seed must go up the size of da1-1 da2-1 double-mutant seed, but be greater than da1-ko1
The size of da2-1 double-mutant seed.Therefore, these genetic analyses further support da1-1 allele to DA1 and DAR1 two
Person has negative effect (Li et al. people, 2008).
We previously authenticated the enhancer (EOD1) of da1-1, and the enhancer is and BIG BROTHER (BB) equipotential
(Disch et al., 2006;Li et al. people, 2008).Eod1 mutation collaboration enhancing da1-1 seed size phenotype (Li et al. people,
2008).Similarly, the Seed size and weight phenotype of da2-1 by da1-1 and da1-ko1 collaboration enhancing (Fig. 3 A, 3C and
3D).Therefore whether inquiry DA2 and EOD1 can be worked with common pathway.In order to which the heredity measured between DA2 and EOD1 is closed
System, we analyze eod1-2da2-1 double-mutant.Heredity compared to its parental department, between eod1-2 and da2-1
Interaction is (Figure 16) being substantially added for both seed weight and petal size, thus provide instruction DA2 with
EOD1 separately works to influence seed and organ growth.
Act on to influence seed size to 2.3 DA2 parents
In view of the size of seed is by parent and/or zygote tissue effect, inquire DA2 be parent work or zygote
It works on ground.In order to test this point, We conducted the reciprocal cross experiments between wild type and da2-1.As shown in Figure 6,
Only effect of the da2-1 to seed size is observed when it is homozygosis that maternal plant is for da2-1 mutation.Regardless of pollen donor
Genotype, the seed that is generated by parent wild-type plant is consistently greater than by the seed that parent da2-1 plant generates.This result
Instruction da2-1 can act on to parent to influence seed size.Previously we worked to control kind with being proved DA1 also parent
Sub- size (Li et al. people 2008).Since da1-ko1 is mutated the seed size phenotype (Fig. 3 D) of collaboration enhancing da2-1, we are into one
Step has carried out the experiment of the reciprocal cross between wild type and da1-ko1 da2-1 double-mutant.Similarly, only in da1-ko1 da2-
1 observes effect (Fig. 6) of the da1-ko1 da2-1 to seed size when serving as maternal plant.
Da1-ko1/+ is caused to da1-ko1/+da2-1/+ plant pollination with da1-ko1 da2-1 double-mutant pollen
The intracutaneous da1-ko1 da2-1 of da2-1/+ kind, da1-ko1/da1-ko1 da2-1/+, da1-ko1/+da2-1da2-1 and
The development of da1-ko1/+da2-1/+ plumule.It further measures come da1-ko1 da2-1 double-mutant pollen fertilization of using by oneself
The size of the single seed of da1-ko1/+da2-1/+ plant and to da1-ko1 and da2-1 mutation carry out Genotyping.As a result
Show that da1-ko1 and da2-1 is mutated (Fig. 6) uncorrelated to the variation of the size of these seeds.In short, these analysis instructions DA1
Will not influence seed size with the plumule of DA2 and the genotype of endosperm, and need in the sporophytic tissues of maternal plant DA1 and
DA2 is to control seed growth.
2.4 DA2 and DA1 act synergistically to influence the cell Proliferation in parent integument
Reciprocal cross works to determine seed size (Fig. 6) (Li et al. people, 2008) with showing DA1 and DA2 parent.Around embryo
The integument of pearl is maternal tissue and forms kind of a skin after fertilization, can physically limit seed growth.Several studies have shown that
The integument size of ovule determine seed size (Schruff et al., 2006;Adamski et al., 2009).Therefore inquiry DA1 and
Whether DA2 is acted on by parent integument to control seed size.In order to test this point, we have studied 2 days after emasculation
When the mature ovule from wild type, da1-1, da2-1 and da1-1 da2-1.Previous discovery (the Li et al. people, 2008) with us
Unanimously, the size (Fig. 5 and 7) for being sized significantly greater than wild type ovule of da1-1 ovule.
Da2-1 ovule is also greater than wild type ovule (Fig. 5 and 7).The ovule size table of da2-1 mutation collaboration enhancing da1-1
Type, this is consistent with its cooperative interaction in terms of seed size.
We have studied wild types, the positive development seed in da1-1, da2-1 and da1-1 da2-1 in 6DAP and 8DAP
External integument cell number.In wild type seeds, in 6DAP, the number of external integument cell is similar to the external integument in 8DAP
The number (Fig. 7 middle graph) of cell, to indicate that the cell in the external integument of wild type seeds stops dividing completely in 6DAP.
Similarly, the cell in the external integument of da1-1, da2-1 and da1-1 da2-1 seed stops cell Proliferation in 6DAP completely.
Compared to the number of the external integument cell in wild type seeds, the number of the external integument cell in da1-1 and da2-1 seed is significant
Increase (Fig. 7).The external integument cell number of da2-1 mutation collaboration enhancing da1-1.We further study after pollination 6 days
With the external integument cell length of wild type at 8 days, da1-1, da2-1 and da1-1 da2-1 seed.Da1-1, da2-1 and da1-1
Cell in da2-1 external integument is considerably shorter than the cell (Fig. 7 right figure) in wild type external integument, increases to provide cell in integument
Grow the instruction of the compensation mechanism between cell amplification.Therefore, these are the result shows that DA2 and DA1 acts synergistically to limit parent
Cell Proliferation in integument.
2.5 DA2 encoding function E3 ubiquitin ligases
It authenticated da2-1 mutation (Fig. 8 A) in the case that T-DNA is inserted into the 7th exon of Gene A t1g78420.
Using T-DNA specificity and flank primer and sequencing PCR product by PCR further confirms T-DNA insertion point.
The full length mRNA of At1g78420 fails to detect in da2-1 mutant by Semiquatitative RT-PCR assay.We are in da2-1 plant
With in 62 kinds of transgenic plants of separation their own promoter control under express At1g78420CDS.Almost all of turn
Gene line shows the complementation (Figure 10) of da2-1 phenotype, to indicate that At1g78420 is DA2 gene.
In order to further characterize DA2 function, the specifically acquired phenotype of function, in WT lines and 77 kinds of separation
The code area of DA2 is expressed in transgenic plant under the control of CaMV 35S promoter.The overexpression of DA2 causes seed big
The reduction (Figure 1A, 1C and 1D) of the number seeds of the seed production and every plant of small, every plant.In addition, compared to wild type,
The most of transgenic plants for over-expressing DA2 have compared with little Hua and leaf, compared with silicle, the plant height of reduction and reduction
Biomass (Fig. 1 E, 2 and 15).These results further support effect of the DA2 in limitation seed and organ growth.
Predict the protein of 402 amino acid of the RING structural domain (59-101) that DA2 gene coding is predicted containing one
(Fig. 8 B;Table 1).In order to study whether DA2 has E3 ubiquitin ligase activity, we are in expression in escherichia coli DA2, by it
MBP-DA2 albumen is purified as the fusion protein with maltose-binding protein (MBP), and from soluble fraction.In E1 ubiquitin activating
In the presence of enzyme, E2 conjugated enzyme, His- ubiquitin and MBP-DA2, poly- ubiquitin is observed by Western blotting using anti-His antibody
Change signal (Fig. 9, from the 5th swimming lane of the left side).Anti- MBP engram analysis also indicates that MBP-DA2 by ubiquitination (Fig. 9, from the left side the 5th
Swimming lane).However, in the absence of any one of E1, E2, His- ubiquitin or MBP-DA2, be not detected poly- ubiquitination (Fig. 9,
From first to fourth swimming lane of the left side), to prove that DA2 is functional E3 ubiquitin ligase.RING motif is for RING zinc finger egg
It is required (Xie et al., 2002) for white E3 ubiquitin ligase activity.Therefore, we have detected complete RING zinc finger knot
Whether structure domain is needed for DA2 E3 connection enzymatic activity.List is generated by the way that cysteine -59 is sported serine (C59S)
Amino acid substitution allele, because predicting that this mutation destroys RING structural domain (table 1 and 2).External ubiquitination measurement instruction E3
Connection enzymatic activity is eliminated (Fig. 9, from the 6th swimming lane of the left side) in the C59S mutant of DA2, to indicate complete RING structure
Domain is needed for DA2 E3 ubiquitin ligase activity.We are further in 69 kinds of transgenosis of wild type Col-0 plant and separation
DA2 C59S (35S:DA2C59S) has been over-expressed in plant.The seed size of transgenic plant is comparable to WT lines
Seed size, but transgenic plant have high DA2 C59S expression, thus indicate DA2 C59S mutation influence DA2 exist
Function in terms of seed growth.
Three kinds of RING type RING-H2, RING-Hca and RING-HCb are described in arabidopsis and five kinds are repaired
RING type RING-C2, RING-v, RING-D, RING-S/T and RING-G (Stone et al., 2005) of decorations.It proposes in water
The RING structural domain (C5HC2) (Song et al., 2007) of the new type found in rice GW2.Although the RING structure of the prediction of DA2
The spacing of cysteine in domain is similar to the spacing of the cysteine in the RING structural domain (C5HC2) of rice GW2, but DA2
RING structural domain lack the conservative histidine residues (Asn-91) (table 1 and 2) that are substituted by asparagine residue.Also in Shuangzi
This amino acid substitution (table 1) is observed in the RING structural domain of the prediction of DA2 homologue in leaf plant such as soybean and rape.Cause
This inquires whether this asparagine residue (Asn-91) is crucial for its E3 ubiquitin ligase activity.By by Asn-
91 sport leucine (N91L) to generate monamino acid and replace allele.External ubiquitination measurement shows that the N91L of DA2 is prominent
Variant has E3 connection enzymatic activity (Fig. 9, from the 7th swimming lane of the left side), to show that Asn-91 may not be DA2E3 connection enzyme activity
Needed for property.These are the result shows that the RING structural domain of DA2 can be the variant of the RING structural domain found in GW2.We
Further DA2 N91L (35S:DA2N91L) has been over-expressed in WT lines and 26 kinds of transgenic plants of separation.Turn
The seed of gene plant is less than wild type seeds, to show that DA2N91L can limit seed growth.
The homologue of 2.6 arabidopsis DA2
With the DA2 outside RING structural domain share the protein of significant homology arabidopsis and crop include rape, it is big
(table 2) is found in beans, rice, corn and barley.The protein and DA2 of one of arabidopsis prediction share extensive amino
Sour similitude and it is named as DA2 sample albumen (DA2L;At1g17145).As 35S:DA2 plant, DA2L overexpression
System show compared with plantlet and organ (Figure 18), thus provide instruction DA2 have the function of with DA2L it is similar.Other plant species
In analogous protein show with 39.2% -84.5% amino acid sequence identity (table 2) of DA2.It is same in cabbage type rape
Source object and DA2 have highest amino acid sequence identity (84.5%) (table 2).Rice GW2 and arabidopsis DA2 has 43.1% ammonia
Base acid sequence identity (table 2).Since the grain that the overexpression of GW2 reduces in rice is wide (Song et al., 2007), therefore inquire
Whether DA2 exercises similar function with GW2 in terms of seed size control.Therefore GW2 has been over-expressed in WT lines.
As 35S:DA2 and 35S:DA2L transgenosis system, WT lines are compared in the arabidopsis transgenic plant generation for over-expressing GW2
Smaller seed and organ, to indicate the conservative function of arabidopsis DA2 and rice GW2 in terms of seed and organ growth control
Energy.
2.7 DA2 show similar expression pattern with DA1
In order to measure the expression pattern of DA2, the RNA from root, stem, leaf, seedling and inflorescence is passed through into quantitatively real-time RT-
PCR is analyzed.DA2 mRNA (Figure 11 A) is detected in all plant organs tested.Start using containing DA2
Son: the active histochemistry's measurement of the GUS of the transgenic plant of GUS (pDA2:GUS) fusion has studied the tissue specificity of DA2
Expression pattern.Detect that GUS is active (Figure 11 B and 11C) in root, cotyledon, leaf and inflorescence.It is detected in phyllopodium and root
Relatively high GUS is active (Figure 11 B and 11C).In spending, observed in young flower organ relatively more stronger than in presbyopic organ
DA2 expresses (Figure 11 D-11L).Similarly, detected in compared with rataria pearl higher GUS activity in the old ovule of comparison (Figure 11 M and
11N).This shows that DA2 expression is regulated and controled over time and space.
2.8 DA1 and DA2 interacts in vitro and in vivo
Our genetic analysis shows DA1 and DA2 synergistic effect to limit seed and organ growth.Therefore external phase is used
Interaction/involve whether Experimental Evaluation DA1 interacts with E3 ubiquitin ligase DA2.DA1 is expressed as gst fusion protein, and
DA2 is expressed as MBP fusion protein.As shown in Figure 12 (from the first and second swimming lane of the left side), GST-DA1 is bound to MBP-
DA2, and GST-DA1 is not associated with to negative control (MBP).This result instruction DA1 and DA2 physically interacts in vitro.
DA1 includes two ubiquitin interactions motif (UIM), single LIM domain and highly conserved C-terminal region
(Figure 13) (Li et al. people, 2008).Further which structural domain of inquiry DA1 is needed for the interaction between DA1 and DA2.
It will be in a series of DA1 derivatives containing specific protein structural domain of expression in escherichia coli: UIM structural domain there are two containing only
DA1-UIM, only with LIM domain DA1-LIM, the DA1-LIM+C only containing LIM domain and C-terminal region and
Only the DA1-C with C-terminal region is expressed as gst fusion protein (Figure 13).
DA2 is expressed as MBP fusion protein and is used to involve in experiment.As shown in Figure 12, GST-DA1-LIM+C and
GST-DA1-C and MBP-DA2 interacts, but GST-DA1-UIM and GST-DA1-LIM are not associated with to MBP-DA2.This result
The conservative C-terminal region and DA2 for indicating DA1 interact.
There is the mutation in C-terminal region in view of the mutant protein encoded by da1-1 allele (DA1R358K)
Whether (Figure 13) (Li et al. people, 2008), inquiry DA1R358K mutation influence the interaction with DA2.In leading with MBP-DA2
GST-DA1R358K fusion protein is used in experiment out, we show that the mutation in DA1R358K does not influence between DA1 and DA2
It interacts (Figure 12, from left side third swimming lane).
In order to further study in plant possible correlation between DA1 and DA2, detected using co-immunoprecipitation analysis
It interacts in vivo.35S:Myc-DA1 and 35S:GFP-DA2 are instantaneously co-expressed in Ben's Tobacco Leaf.In Ben's Tobacco Leaf
In instantaneously co-express 35S:GFP and 35S:Myc-DA1 as negative control.By gross protein separate and with GFP-Trap-A agar
Sugared bead is incubated with immunoprecipitation GFP-DA2 or GFP.Respectively with anti-GFP and anti-Myc antibody test sediment.Such as Figure 14
Shown in, Myc-DA1 is detected in the GFP-DA2 compound of immunoprecipitation, but is not detected in negative control (GFP),
To which instruction is there are physical correlations between DA1 and DA2 in plant.Because involve measurement in DA1 C-terminal region with
DA2 interacts (Figure 12), so further whether the C-terminal of inquiry DA1 in plant interacts with DA2.It is immunized coprecipitated
It forms sediment analysis shows that detect the C-terminal region (Myc-DA1-C) of DA1 in GFP-DA2 compound, but not in negative control
Detected in (PEX10-GFP, a kind of RING type E3 ubiquitin ligase) (Platta et al., 2009;Kaur et al., 2013).Cause
This, the C-terminal region of these results instruction DA1 is needed for interacting in vitro and in vivo with DA2.
Seed size in higher plant is the key determinant of evolutionary adaptability, and the still weight in Crop Domestication
Want economical character (Gomez, 2004;Orsi and Tanksley, 2009).
It acts on having authenticated parent to control several factors of seed size, such as ARF2/MNT, AP2, KLU/
CYP78A5, EOD3/CYP78A6 and DA1.However, heredity and molecular mechanism of these factors in seed size control are almost
Totally unknown.It is big to control seed that we had previously demonstrated ubiquitin receptor DA1 and E3 ubiquitin ligase EOD1/BB synergistic effect
Small (Li et al. people, 2008).
In this research, we, which authenticated, participates in control kind as the arabidopsis DA2 of another RING E3 ubiquitin ligase
Sub- size.Genetic analysis shows DA2 and DA1 co-action to control final seed size, but independently of E3 ubiquitinbond
Enzyme EOD1 controls final seed size.We further disclose DA1 and DA2 and physically interact.Our result is fixed
The final seed size of justice control arabidopsis is related to the system based on ubiquitin of DA1, DA2 and EOD1.
Act on to control seed size to 2.9 DA2 parents
Da2-1 afunction mutant forms big seed and organ, and the plant for over-expressing DA2 generates small seed
With organ (Figure 1A), thus indicate DA2 be seed and organ size control the negative factor.Unexpectedly, arabidopsis DA2 is nearest
It is proposed as the positive regulatory factor of organ growth, although how to control seed about DA2 and organ growth is known nothing
(Van Daele et al., 2012).In this research, we have enough evidences to prove that DA2 serves as seed and organ growth control
The negative factor of system.Da2-1 afunction mutant forms big seed and organ (Fig. 1 to 4).Da2-1 mutation collaboration enhancing
The seed and organ size phenotype (Fig. 1 to 4) of da1-1 and da1-ko1 supports this point.Da2-1 mutation also enhances eod1-2
Seed and organ size phenotype, so that further instruction da2-1 mutation promotes seed and organ growth.Da2-1 mutant exists
The big ovule with more many cells, and the ovule size phenotype (Fig. 6) of da2-1 mutation collaboration enhancing da1-1 are formed in integument.
In addition, most of transgenic plants of overexpression DA2 and DA2L are (Fig. 2 smaller than WT lines;Scheme S9).This
The corresponding expression of organ growth phenotype of a little transgenic plants is related (figure S4 and S9).Therefore, our data understand
Ground proves that DA2 serves as the negative regulatory factor of seed and organ size.Several Arabidopsis Mutants with big organ are also formed greatly
Seed (Krizek, 1999;Mizukami and Fischer, 2000;Schruff et al., 2006;Li et al. people, 2008;Adamski
Et al., 2009), to show that the possibility between organ size and seed growth contacts.In contrast, several with big organ
Other mutant show normal size seed (Hu et al., 2003;White, 2006;Xu and Li, 2011), thus indicator
Official and seed size be not always positively related.These are the result shows that there is shared and different approach to control it for seed and organ
Corresponding size.
Reciprocal cross experiment acts on to influence seed growth with showing DA2 parent, and the plumule of DA2 and endosperm genotype are not
It will affect seed size (Fig. 6).Integument around ovule is maternal tissue and forms kind of a skin after fertilization.Parent integument is big
Known variation (the Schruff for facilitating seed size of small change those of (such as observed in arf2, da1-1 and klu ovule)
Et al., 2006;Li et al. people, 2008;Adamski et al., 2009).Mature da2-1 ovule is also greater than mature wild type ovule (Fig. 5
With 7).The integument size of da2-1 mutation also collaboration enhancing da1-1 ovule.It therefore, is control from total theme that these researchs show
Parent integument size is one of the key mechanism for determining final seed size.It is of the same mind with this, it separates so far
Seed size control plant maternal factor (such as KLU, ARF2 and DA1) influence integument size (Schruff et al., 2006;Li
Et al., 2008;Adamski et al., 2009).
Integument or the size for planting skin are to expand by cell Proliferation and cell the processes of the two coordinations to determine.It is mature
Cell number in the integument of ovule sets the growth potential that skin is planted after fertilization.For example, the generation of arf2 mutant has
The big ovule of more many cells, so that big seed (Schruff et al. 2006) is generated, and klu mutant has less cell
Small ovule, to generate seedlet (Adamski et al., 2009).Our result indicate that the integument of da1-1 and da2-1 seed
There are more many cells than the integument of wild type seeds, and da1-1 and da2-1 synergistic effect is to promote the cell in integument to increase
It grows.We have also observed that the cell in the external integument of da1-1, da2-1 and da1-1 da2-1 seed is than thin in wild type integument
Born of the same parents are shorter, to show the possible compensation mechanism in parent integument between cell Proliferation and cell elongation.Therefore, it is possible to fill
When the parent integument or kind skin of the physical constraint of seed growth can set the upper limit of final seed size.
The hereditary frame of the 2.10 seed size controls mediated for ubiquitin
DA2 coding has the RING knot of a prediction of any one of plant RING structural domain different from the previously described
The protein in structure domain.The RING structural domain of DA2 and the RING structural domain of rice GW2 (C5HC2) share highest homology, but it is lacked
A kind of weary conservative metal ligand amino acid (histidine residues) (Song et al., 2007) substituted by asparagine residue.Still
The RING structural domain for being so possible to DA2 can be the variant of the RING structural domain found in GW2.Many RING type structural domains exist
Be found in E3 ubiquitin ligase, ubiquitination substrate often target they to subsequent proteasome degradation (Smalle and
Vierstra, 2004).It is function that we, which test the E3 activity for recombinating DA2 in external ubiquitinbond enzymatic determination and demonstrate DA2,
Can property E3 ubiquitin ligase, thus show DA2 can target the positive regulatory factor of cell Proliferation with for by 26S proteasome into
The degradation of row ubiquitin dependence.The protein of homology is shared in arabidopsis and other plant object with the DA2 outside RING structural domain
It is found in kind.In arabidopsis, DA2 sample albumen (DA2L) and DA2 share extensive amino acid similarity.It is planted with 35S:DA2
Strain is the same, and DA2L overexpression system shows compared with plantlet (Figure 18), to indicate that DA2 can exercise similar function with DA2L.
The homologue of DA2 is RING type (C5HC2) Protein G W2 (Song et al., 2007) in rice, known to serve as the negative of seed size
Regulatory factor.However, heredity and molecular mechanism of the GW2 in seed size control are largely unknown in rice
's.
We previously authenticated DA1, and there is one kind ubiquitin to combine active ubiquitin receptor, the negative regulation as seed size
The factor (Li et al. people, 2008).Modifier screens a kind of enhancer (EOD1) (Li et al. people, 2008) that authenticated da1-1, described
Enhancer is and E3 ubiquitin ligase BB equipotential (Disch et al., 2006).The analysis of double eod1-2da1-1 mutant discloses
Genetic interaction (Li et al. people, 2008) is cooperateed between DA1 and EOD1, to show that they can be by adjusting shared target
Activity controls seed growth.Although the genetic interaction between da1-1 and eod1-2 also cooperates with enhancing seed and organ big
It is small, but genetic analysis shows DA2 independently of EOD1 effect to influence seed growth, is used for show that DA2 and EOD1 can be targeted
The different growth stimulants of degradation, wherein regulating and controlling jointly via DA1.Therefore, our discovery is established through three kinds of ubiquitin phases
3-protein d A1, DA2 and EOD1 of pass are used to control the frame of seed and organ size.In addition, it is observed that GW2's is excessive
Seed and organ growth in expression limitation arabidopsis, to provide the finger of the possible conservative function in arabidopsis and rice
Show.The combination for studying the rice homologue of GW2 and DA1 and EOD1 in rice may be very interesting to the effect of grain size.
Possible molecular mechanism of 2.11 DA1 and DA2 in seed size control
Our result proves that E3 ubiquitin ligase DA2 and ubiquitin receptor DA1 interact (Figure 12-in vitro and in vivo
14).However, it is unlikely be DA2 targeting DA1 with for proteasome degrade because the T-DNA of DA1 gene be inserted into dash forward
The seed size phenotype (Fig. 3 and 4) of variant (da1-ko1) collaboration enhancing da2-1.However, many other types of ubiquitin modification
Regulation protein (Schnell and the Hicke, 2003) in a manner of proteasome dependent/non-dependent.For example, single ubiquitination is involved in always
In the activation of signal conductive protein, endocytosis and histone modification (Schnell and Hicke, 2003).In animal, ubiquitin
Single ubiquitination of receptor eps15 depend on eps15 and E3 ligase Nedd4 family between interaction (Woelk et al.,
2006).In contrast, it is also reported that the E3 dependent/non-dependent list ubiquitination (Hoeller et al., 2007) of ubiquitin receptor.It considers
DA1 and DA2 interacts, and whether we test DA2 being capable of ubiquitination or single ubiquitination DA1.Exist in E1, E2 and ubiquitin
Under, DA2-His has E3 ubiquitin ligase activity.However, in the presence of E1, E2, ubiquitin and DA2-His (E3), ours
The DA1-HA of ubiquitination is not detected under reaction condition.Ubiquitin receptor can be via the bottom of the poly- ubiquitination of structural domain UIM and E3
Object interaction, and promote it to degrade (Verma etc., 2004) by proteasome.We had previously demonstrated the UIM knot of DA1
Structure domain can combine ubiquitin (Li et al. people, 2008).
In short, DA1 may participate in mediation in the case where DA1 is interacted by its C-terminal area and DA2 (Figure 12 and 14)
Pass through the ubiquitination substrate of proteasome degradation DA2.A kind of mechanism can be related to the interaction of DA1 and DA2, facilitate DA1
Specifically identify the ubiquitination substrate of DA2.DA1 then can pass through the poly-ubiquitin chain of its UIM structural domain combination ubiquitination substrate
And mediate the degradation of the poly- ubiquitination substrate.The important goal that seed production is crop breeding in worldwide is improved,
And the size of seed is the important component of total seed production.We authenticated important regulating and controlling of the DA2 as seed size
The factor influences seed size with DA1 co-action.
DA1 also influences seed growth with EOD1 synergistic effect.Dominant negative da1-1 is mutated the excessive of (Zmda1-1)
Expression it is reported that increase the seed quality (Wang etc., 2012) of cereal, this demonstrate combine DA1 from different seed crops,
The effect of DA2 and EOD1 in these crops to be engineered the prospect of big seed size.
Bibliography
Adamski, N.M. et al. (2009) PNAS USA 106,20115-20120.
Alexandru, G. et al. (2008) Cell 134,804-816.
Alonso-Blanco, C. et al. (1999) .PNAS USA 96,4710-4717.
Bandau, S. et al. (2012) BMC Biol 10,36.
Bednarek, J. et al. J.Exp.Bot. (2012) 63165945-5955
Curtis, M.D. et al. (2003) Plant physiology 133,462-469.
Disch, S. et al. (2006) Curr Biol 16,272-279.
Fan, C. et al. (2006) Theor Appl Genet 112,1164-1171.
Fang, W. et al. (2012) Plant J 70,929-939.
Garcia, D. et al. (2005) Plant Cell 17,52-60.
Garcia,D.et al(2003)Plant Physiology 131,1661-1670.
Gegas, V.C. et al. (2010) Plant Cell 22,1046-1056.
Gomez,J.M.(200)Int J Org Evol 58,71-80.
Hoeller, D. et al. (2007) Mol Cell 26,891-898.
Hu, Y. et al. (2003) Plant Cell 15,1951-1961.
Jofuku,K.D.et al.(2005)PNAS USA 102,3117-3122.
Kaur, N. et al. (2013) .J Int Plant Biol 55,108-120.
Krizek,B.A.(1999.Dev Genet 25,224-236.
Lanctot, A.A. et al. (2013) .Developmental cell 25,241-255.
Li, Y., et al. (2008) Genes Dev 22,1331-1336.
Li, Y. et al. (2006) Genome Res 16,414-427.
Lopes, M.A. et al. (1993) Plant Cell 5,1383-1399.
Luo, M. et al. (2005) PNAS USA 102,17531-17536.
Mizukami, Y et al. (2000) PNAS USA 97,942-947.
Moles, A.T. et al. (2005) Science 307,576-580.
Ohto, M.A., et al. (2005) PNAS USA 102,3123-3128.
Ohto, M.A. et al. (2009) Sex Plant Reprod 22,277-289.
Orsi, C.H. et al. (2009) PLoS Genet 5, e1000347.
Perez-Perez, J.M. et al. (2009) Trends Genet 25,368-376.
Platta, H.W. et al. (2009) Mol Cell Biol 29,5505-5516.
Schnell, J.D. et al. (2003) J Biol Chem 278,35857-35860.
Schruff, M.C. et al. (2006) Development 133,251-261.
Seo, H.S. et al. (2003) Nature 423,995-999.
Shomura, A., et al. (2008) Nat Genet 40,1023-1028.
Smalle, J. et al. (2004) Annual review of plant biology 55,555-590.
Song, X.J. et al. (2007) Nat Genet 39,623-630.
Stone, S.L. et al. (2005) Plant physiology 137,13-30.
Van Daele, I. et al. (2012) Plant Biotech J 10,488-500.
Verma, R. et al. (2004) Cell 118,99-110.
Voinnet, O. et al. (2003) Plant J 33,949-956.
Wang, A. et al. (2010) Plant J.
Wang, et al. (2012) Afrian Journal of Biotechnology 11,13387-13395.
Weng, J. et al. (2008) Cell Res 18,1199-1209.
Westoby, M. et al. (2002) Ann.Rev.Ecol.System.33,125-159.
White,D.W.(2006)PNAS USA 103,13238-13243.
Woelk, T. et al. (2006) Nat Cell Biol 8,1246-1254.
Xie, Q. et al. (2002) Nature 419,167-170.
Xu, R. et al. (2011) Development 138,4545-4554.
Zhou, Y. et al. (2009) Plant Cell 21,106-117.
The comparison (SEQ ID NO:3-19) of table 1:DA2 RING structural domain.
The comparison (SEQ ID NO:20-35) of table 2:DA2 polypeptide
* identical residue is indicated
: indicate conservative residue
Semi-conservative residue is indicated
RING structural domain and the first and second apokoinou construction domains add frame.
The comparison (SEQ ID NO:41-64) of table 3:DA1 albumen
The comparison (SEQ ID NO:74-90) of table 4:EOD1 albumen
Claims (34)
1. a kind of quality, the method for the size of seed and organ of the per unit area seed for increasing plant, which comprises
The expression or activity of the intracellular DA2 polypeptide of the plant are reduced,
Wherein, the DA2 polypeptide includes the RING structural domain of SEQ ID NO:2, and wherein the plant has reduced DA1
Or reduced DA1 and EOD1 expression or activity.
2. according to the method described in claim 1, wherein the plant expresses dominant negative DA1 polypeptide.
3. according to claim 1 or method as claimed in claim 2, wherein the expression of the DA2 polypeptide or activity are in the plant
It is eliminated in the cell of object.
4. a kind of quality, the method for the size of seed and organ of the per unit area seed for increasing plant, which comprises
The expression or activity of DA2 polypeptide are reduced, and;
The expression of the intracellular DA1 polypeptide of the plant or the expression or activity of activity or DA1 polypeptide and EOD polypeptide are reduced,
Wherein, the DA2 polypeptide includes the RING structural domain of SEQ ID NO:2.
5. according to the method described in claim 4, wherein by that will be mutated in the nucleotide sequence for being introduced into the plant cell simultaneously
And plant described in the cytothesis from mutation reduces the expression or activity of the EOD1 polypeptide, the nucleotide sequence coded institute
It states EOD1 polypeptide or regulates and controls its expression.
6. according to the method described in claim 4, wherein by heterologous nucleic acids are incorporated in the plant cell reduce it is described
The expression or activity of EOD1 polypeptide, the heterologous nucleic acids expression reduce the repressor nucleic acid of the expression of the EOD1 polypeptide.
7. according to the method described in claim 6, wherein by that will be mutated in the nucleotide sequence for being introduced into the plant cell simultaneously
And plant described in the cytothesis from mutation reduces the expression or activity of the DA1 polypeptide, the nucleotide sequence coded institute
It states DA1 polypeptide or regulates and controls its expression.
8. according to the method described in claim 6, wherein by heterologous nucleic acids are incorporated in the plant cell reduce it is described
The expression or activity of DA1 polypeptide, the heterologous nucleic acids expression reduce the repressor nucleic acid of the expression of the DA1 polypeptide.
9. according to the method described in claim 6, wherein passing through the dominant negative DA1 polypeptide of cell inner expression in the plant
To reduce the expression or activity of the DA1 polypeptide.
10. the method according to any one of claim 4 to 9, wherein by the way that the core for introducing the plant cell will be mutated
Plant described in cytothesis in nucleotide sequence and from mutation reduces the expression or activity of the DA2 polypeptide, the nucleosides
DA2 polypeptide described in sequences code regulates and controls its expression.
11. the method according to any one of claim 4 to 9, wherein by the way that heterologous nucleic acids are incorporated to the plant cell
In reduce the expression or activity of the DA2 polypeptide, the heterologous nucleic acids expression reduces the repressor of the expression of the DA2 polypeptide
Nucleic acid.
12. the method according to any one of claim 4 to 9, wherein the expression of the DA2 polypeptide or activity are in the plant
It is eliminated in the cell of object.
13. a kind of method for the plant for generating the quality, the size of seed and organ with increased per unit area seed, institute
The method of stating includes:
The expression for lacking both DA1 or DA1 and EOD1 or active plant cell are provided,
The expression for reducing DA2 polypeptide or active heterologous nucleic acids are incorporated to, the DA2 polypeptide includes the RING knot of SEQ ID NO:2
Structure domain;Or the expression for reducing DA2 polypeptide or active mutation are introduced into the plant cell, the DA2 polypeptide includes SEQ
The RING structural domain of ID NO:2, and;
Plant described in cytothesis from one or more conversion.
14. according to the method for claim 13, wherein the plant cell includes the nucleotide sequence of the plant cell
In mutation, the nucleotide sequence coded EOD1 polypeptide or regulate and control its expression;Or another heterologous nucleic acids, the heterologous core
Acid expression reduces the repressor nucleic acid of the expression of the EOD1 polypeptide in the plant cell.
15. according to claim 13 or method of claim 14, wherein the plant cell lack DA1 polypeptide expression or
Activity.
16. according to the method for claim 15, wherein the plant cell includes the nucleotide sequence of the plant cell
In mutation, the nucleotide sequence coded DA1 polypeptide or regulate and control its expression;Another heterologous nucleic acids, the heterologous nucleic acids
Expression reduces the repressor nucleic acid of the expression of the DA1 polypeptide in the plant cell;Or another heterologous nucleic acids, it is described heterologous
Cell inner expression dominant negative DA1 polypeptide of the nucleic acid in the plant.
17. according to the method for claim 13, wherein the heterologous nucleic acids expression inhibiting daughter nucleus acid is to the plant cell
In, the repressor nucleic acid reduces the expression of the DA2 polypeptide.
18. according to the method for claim 13, wherein the heterologous nucleic acids eliminate the DA2 polypeptide in the cell of the plant
Expression or activity.
19. according to claim 1, method described in any one of 4 or 13, wherein the DA polypeptide of encoding dominant negative feminine gender and/or suppression
The nucleic acid of system nucleic acid is operably coupled to allogeneic promoter.
20. according to the method for claim 19, wherein the promoter is tissue-specific promoter.
21. according to the method for claim 20, wherein the promoter is inducible promoter.
22. according to claim 1, method described in any one of 4 or 13, wherein heterologous nucleic acids are included in one or more loads
In body.
23. according to claim 1 or method as claimed in claim 4, the method includes sexual or vegetative propagation or growth tools
There are DA2 expression or filial generation or the offspring of the active plant of reduction.
24. according to claim 1, method described in any one of 4 or 13, wherein the DA2 polypeptide includes SEQ ID NO:36
The first apokoinou construction domain.
25. according to claim 1, method described in any one of 4 or 13, wherein the DA2 polypeptide includes SEQ ID NO:37
The second apokoinou construction domain.
26. according to claim 1, method described in any one of 4 or 13, wherein the DA2 polypeptide includes according to SEQ ID
The amino acid sequence of NO:20 to any one of 35.
27. according to claim 1, method described in any one of 4 or 13, wherein the DA1 polypeptide includes SEQ ID NO:38
Or 39 LIM domain.
28. according to the method for claim 27, wherein the DA1 polypeptide includes C-terminal region, the C-terminal region packet
Include the residue 229 to 532 of SEQ ID NO:45.
29. according to the method for claim 27, wherein the DA1 albumen includes according to appointing in SEQ ID NO:41 to 64
The sequence of one.
30. according to the method for claim 28, wherein the DA1 albumen includes according to appointing in SEQ ID NO:41 to 64
The sequence of one.
31. according to claim 1, method described in any one of 4 or 13, wherein to be included in the DA1 more by dominant negative DA1
The R to K at the position of the position 358 of the DA1 polypeptide of SEQ ID NO:45 is equivalent in the amino acid sequence of peptide to replace.
32. according to claim 1, method described in any one of 4 or 13, wherein the EOD1 polypeptide includes according to SEQ ID
The sequence of NO:74 to any one of 90.
33. according to claim 1, method described in any one of 4 or 13, wherein the plant is higher plant.
34. according to the method for claim 33, wherein the plant is that the agricultural selected from the group being made of the following terms is planted
Object: Asian puccoon, Taxus, tobacco, cucurbit, carrot, Vegetables in Brassica, melon, capsicum, vine, lettuce, strawberry, Brassica genus
Oily seed, beet, wheat, barley, corn, rice, soybean, pea, jowar, sunflower, tomato, potato, pepper, chrysanthemum
Flower, carnation, linseed, hemp and rye.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911047871.8A CN110964739A (en) | 2013-08-14 | 2014-07-30 | Methods of modulating seed and organ size in plants |
CN201480045197.9A CN105612171B (en) | 2013-08-14 | 2014-07-30 | The method for adjusting the seed in plant and organ size |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013081457 | 2013-08-14 | ||
CNPCT/CN2013/081457 | 2013-08-14 | ||
PCT/EP2014/066427 WO2015022192A1 (en) | 2013-08-14 | 2014-07-30 | Methods of modulating seed and organ size in plants |
CN201480045197.9A CN105612171B (en) | 2013-08-14 | 2014-07-30 | The method for adjusting the seed in plant and organ size |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911047871.8A Division CN110964739A (en) | 2013-08-14 | 2014-07-30 | Methods of modulating seed and organ size in plants |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105612171A CN105612171A (en) | 2016-05-25 |
CN105612171B true CN105612171B (en) | 2019-11-26 |
Family
ID=55991260
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911047871.8A Pending CN110964739A (en) | 2013-08-14 | 2014-07-30 | Methods of modulating seed and organ size in plants |
CN201480045197.9A Active CN105612171B (en) | 2013-08-14 | 2014-07-30 | The method for adjusting the seed in plant and organ size |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911047871.8A Pending CN110964739A (en) | 2013-08-14 | 2014-07-30 | Methods of modulating seed and organ size in plants |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN110964739A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111172179A (en) * | 2020-01-19 | 2020-05-19 | 武汉艾迪晶生物科技有限公司 | Ubiquitin ligase gene OsNLA2, protein and application thereof in rice breeding |
WO2023192855A3 (en) * | 2022-03-29 | 2023-11-09 | Monsanto Technology Llc | Compositions and methods for enhancing corn traits and yield using genome editing |
WO2023192860A3 (en) * | 2022-03-29 | 2024-01-18 | Monsanto Technology Llc | Compositions and methods for enhancing corn traits and yield using genome editing |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108034663B (en) * | 2018-01-04 | 2021-05-07 | 合肥工业大学 | Tomato ubiquitin ligase gene and application thereof |
CN109777812B (en) * | 2019-03-07 | 2023-04-07 | 陕西省杂交油菜研究中心 | Cruciferae dominant petal-free gene and method for creating dominant petal-free germplasm thereof |
CN116535476A (en) * | 2023-04-17 | 2023-08-04 | 西南大学 | Stem tumor mustard BjuDA1 R356K Gene, protein coded by gene and application of gene |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010042575A1 (en) * | 2008-10-08 | 2010-04-15 | Monsanto Technology Llc | Transgenic plants with enhanced agronomic traits |
CN101855353A (en) * | 2007-10-11 | 2010-10-06 | 植物生物科学有限公司 | Methods of controlling plant seed and organ size |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060048240A1 (en) * | 2004-04-01 | 2006-03-02 | Nickolai Alexandrov | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
-
2014
- 2014-07-30 CN CN201911047871.8A patent/CN110964739A/en active Pending
- 2014-07-30 CN CN201480045197.9A patent/CN105612171B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101855353A (en) * | 2007-10-11 | 2010-10-06 | 植物生物科学有限公司 | Methods of controlling plant seed and organ size |
WO2010042575A1 (en) * | 2008-10-08 | 2010-04-15 | Monsanto Technology Llc | Transgenic plants with enhanced agronomic traits |
Non-Patent Citations (2)
Title |
---|
Control of final seed and organ size by the DA1 gene family in Arabidopsis thaliana;Yunhai Li,等;《Genes and Development》;20080515;第22卷(第10期);第1331-1332页第4段 * |
DA1和DA2协同调控植物种子和器官大小;夏天,等;《植物分子生物学与现代农业——全国植物生物学研讨会论文摘要集》;20100718;摘要 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111172179A (en) * | 2020-01-19 | 2020-05-19 | 武汉艾迪晶生物科技有限公司 | Ubiquitin ligase gene OsNLA2, protein and application thereof in rice breeding |
CN111172179B (en) * | 2020-01-19 | 2020-09-08 | 武汉艾迪晶生物科技有限公司 | Ubiquitin ligase gene OsNLA2, protein and application thereof in rice breeding |
WO2023192855A3 (en) * | 2022-03-29 | 2023-11-09 | Monsanto Technology Llc | Compositions and methods for enhancing corn traits and yield using genome editing |
WO2023192860A3 (en) * | 2022-03-29 | 2024-01-18 | Monsanto Technology Llc | Compositions and methods for enhancing corn traits and yield using genome editing |
Also Published As
Publication number | Publication date |
---|---|
CN110964739A (en) | 2020-04-07 |
CN105612171A (en) | 2016-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220056465A1 (en) | Transgenic plants having increased biomass | |
Yang et al. | A mutation in Thermosensitive Male Sterile 1, encoding a heat shock protein with DnaJ and PDI domains, leads to thermosensitive gametophytic male sterility in Arabidopsis | |
US11519001B2 (en) | Methods of modulating seed and organ size in plants | |
CN101855353B (en) | Methods of controlling plant seed and organ size | |
CN105612171B (en) | The method for adjusting the seed in plant and organ size | |
US20130014292A1 (en) | Transgenic plants having increased biomass | |
US20200385750A1 (en) | Methods of controlling seed size in plants | |
EP3169785B1 (en) | Methods of increasing crop yield under abiotic stress | |
CN111154786B (en) | Gene for regulating and controlling plant seed germination and seedling growth, and coding protein and application thereof | |
KR20140143376A (en) | Transcription factors in plants related to levels of nitrate and methods of using the same | |
CN108752443A (en) | Rice CYC U2;1 gene is in the control developmental application of rice mesocotyl | |
Martínez Fernández et al. | Transgenic plants with increased number of fruits and seeds and method for obtaining thereof | |
EA043050B1 (en) | WAYS TO INCREASE GRAIN YIELD | |
Shi | Characterization of Tomato Cytokinin Response Factor Genes SlCRF1 and SlCRF2 in Tomato Growth and Development |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |